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ABSTRACT 
 
 Tissue engineering aims to regenerate lost or damaged tissues and frequently combines 
therapeutic cells, biomaterial scaffolds, and therapeutic molecules in efforts to do so.  One of the 
primary considerations in such therapies is to orchestrate the interactions between these 
components to regulate the desired cellular responses.  This thesis focuses on tuning the 
proliferation of and exogenous protein expression from precursor cells, multipotent stem cells, 
and pluripotent stem cells with the mechanical and chemical properties of hydrogel-based 
synthetic extracellular matrices (ECMs).  First, a synthetic stem cell niche with controlled 
stiffness and density of cell adhesion peptides was developed for spermatogonial stem cell (SSC) 
culture (Chapter 2).  The synthetic stem cell niche allowed for the growth of SSCs in both two-
dimensional (2D) and three-dimensional (3D) cultures, and the proliferation of SSCs was 
influenced by the density of cell adhesion ligands but not by substrate stiffness.  Separately, the 
effects of substrate stiffness on non-viral gene delivery were evaluated for stem and precursor 
cells commonly used in tissue engineering or frequently present at gene delivery sites (Chapter 
3).  The cellular uptake and expression of non-viral genes for fibroblasts, bone marrow stromal 
cells (BMSCs), and myoblasts were regulated by the stiffness of the synthetic ECM.  
Interestingly, the effects of matrix stiffness on non-viral gene delivery were dependent on cell 
type, likely due to differences in cellular sensitivity to matrix mechanics.  Finally, the results 
from the first two sections were used to build an implantable microvascular stamp consisting of 
cells transfected with plasmid DNA encoding vascular endothelial growth factor (VEGF) and a 
hydrogel matrix with tunable stiffness and permeability (Chapter 4).  Overall, the results from 
this thesis may be useful in understanding the role of the extracellular microenvironment in 
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tuning a variety of cellular activities.  Furthermore, the information gained from these studies 
may be instrumental in the design and development of a novel biomaterial to significantly 
enhance the quality of tissue regeneration therapies. 
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CHAPTER 1:  INTRODUCTION 
 
1.1 Tissue engineering 
Tissue engineering is a field that combines engineering and life sciences principles with 
the goal of repairing or replacing lost or damaged tissues (Langer and Vacanti, 1993).  Since the 
field emerged, several tissue engineering products have been commercialized, including artificial 
skin and cartilage (Khademhosseini et al, 2009).  Biomaterials, cells, and therapeutic molecules 
are frequently used in concert to engineer new tissues or regenerate damaged tissues (Hirano and 
Mooney, 2004), and much research has been focused on developing biomaterials for use as tissue 
engineering scaffolds or synthetic cell niches (Griffith and Naughton, 2002; Ratner and Bryant, 
2004; Lutolf and Hubbell, 2005).  Furthermore, harvesting and engineering therapeutic cells 
along with the use of therapeutic molecules is critical to achieve the ultimate goal of engineering 
new tissues (Badylak and Nerem, 2010). 
 
1.1.1 Hydrogels in tissue engineering 
Hydrogels are viscoelastic materials formed from cross-linking hydrophilic polymers 
dissolved in aqueous media.  These materials have been widely used for biological applications 
(Hoffman, 2002; Peppas et al, 2006).  Due to structural similarities to the native extracellular 
matrix (ECM), hydrogels are well-suited for tissue engineering applications (Drury and Mooney, 
2003).  Hydrogels can be used as scaffolds to provide space for tissue regeneration and also as 
synthetic extracellular matrices to deliver cells and therapeutic molecules (Lee and Mooney, 
2001).  Hydrogels can be generally classified as naturally-derived polymers, which include 
collagen, hyaluronic acid, chitosan, and alginate, and synthetic polymers, which include poly(2-
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hydroxyethylmethacrlyate) (HEMA), poly(N-isopropylacrylamide) (PNIPAAm), and 
poly(ethylene glycol) (PEG). 
Depending on their intended applications, hydrogels must present certain physical and 
biological properties.  Physical properties include gel formation mechanisms, mechanical 
properties, and degradation behavior.  Gel formation mechanisms are critical to consider when 
incorporating cells or molecules, as certain processing techniques can kill cells or denature 
molecules of interest (Schmidt et al, 2008).  Implantable scaffolds must present the mechanical 
properties needed to withstand loads encountered in the body while supporting cell growth for 
tissue regeneration.  For tissue engineering applications, it may be necessary to design 
degradable scaffolds to allow new tissue formation or to release therapeutic molecules of 
interest.  Hydrogel scaffolds typically degrade through hydrolysis, enzymatic degradation, or 
dissolution.  The porous structure of hydrogel scaffolds is also an important consideration, as it 
governs the diffusive behaviors of gases, nutrients, proteins, cells, and waste.  While the non-
toxic nature of hydrogels makes them suitable materials for biological applications, most 
hydrogel materials do not support cell adhesion, which is frequently necessary in tissue 
engineering.  Collagen, which is a natural ECM protein, is a notable exception.  Hydrogels also 
do not typically permit protein absorption due to their hydrophilic nature.  Thus, covalent 
modifications are frequently used to couple cell adhesion proteins or therapeutic growth factors 
to hydrogels for tissue engineering applications (Lee and Mooney, 2001; Drury and Mooney, 
2003). 
Collagen is the most abundant protein in mammalian tissues and is one of the most 
widely used naturally-derived hydrogel materials.  Collagen consists of three intertwined 
polypeptide chains which are held together with hydrogen bonds and covalent bonds.  These 
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intertwined chains can self-aggregate to form fibers, which are the structural component in 
collagen hydrogels.  Collagen hydrogels present many ideal biological properties for tissue 
engineering and are enzymatically degradable; however, collagen has limited physical properties.  
Chemical cross-linking with molecules such as gluteraldehyde and formaldehyde has been used 
to improve the physical strength of collagen hydrogels.  Hyaluronic acid is a glycosaminoglycan 
found in the native ECM.  Hyaluronic acid is a linear polysaccharide that can be covalently 
cross-linked with hydrazide derivates to form hydrogels or combined with collagen to form 
composite hydrogels.  Chitosan is a linear polysaccharide derived from chitin, which is found in 
the exoskeletons of arthropods.  Chitosan is structurally similar to glycosaminoglycans and is 
enzymatically degradable.  Ionic or chemical cross-linking methods can be used to form chitosan 
hydrogels (Lee and Mooney, 2001; Drury and Mooney, 2003; Peppas et al, 2006). 
 Poly(HEMA) hydrogels have been used in contact lenses and drug delivery devices.  
PNIPAAm is a temperature-responsive polymer.  The lower critical solution temperature (LCST) 
of PNIPAAm in water is 32°C, and PNIPAAm solutions transition to form hydrogels at 
temperatures above the LCST.  PNIPAAm hydrogels have been used to culture cell sheets 
because the thermal-responsive nature of PNIPAAm allows the cell sheets to be easily isolated 
by decreasing the temperature of the cell-hydrogel construct (Lee and Mooney, 2001; Drury and 
Mooney, 2003; Peppas et al, 2006). 
 
1.1.1.1 Alginate 
Alginate is linear polysaccharide derived from brown algae.  Alginate chains consist of 
blocks of (1,4)-linked β-D-mannuronic acid (M) and α-L-guluronic acid (G).  Both the molecular 
weight and the ratio of M and G blocks can be varied to control the properties of alginate 
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hydrogels.  Carbodiimide chemistry can be used to functionalize alginate molecules by linking 
molecules with amine groups to carboxylate groups on the alginate backbone.  Alginate has been 
widely used in the food industry as an emulsifier and gelling agent.  As a biomaterial, alginate 
has been used in drug delivery, cell encapsulation, dental impressions, and would dressings.  For 
tissue engineering applications, alginate is frequently functionalized to present cell adhesion 
peptides since alginate hydrogels are inherently inert to cell adhesion (Augst et al, 2006).  The 
feasibility of using alginate as a synthetic ECM was first demonstrated in 1999 when Arginine-
Glycine-Aspartic Acid (RGD) cell adhesion peptides were conjugated to alginate hydrogels 
(Rowley et al, 1999). 
To form alginate hydrogels, multivalent cations, such as Ca
2+
 can be used to cross-link 
the G blocks in alginate molecules.  With this approach, the mechanical stiffness of the resulting 
alginate hydrogel can be controlled with the cation concentration (Augst et al, 2006).  
Furthermore, ionically cross-linked alginate hydrogels can be ready dissolved using a chelating 
agent such as ethylenediaminetetraacetic acid (EDTA) (Doner and Becard, 1991).  Alternatively, 
alginate hydrogels can be formed with covalent cross-linking using carbodiimide chemistry.  
Recently, photopolymerizable alginate hydrogels have been synthesized.  In this approach, 
carbodiimide chemistry is first used to conjugate acrylate groups to alginate molecules.  The 
modified alginate molecules are then mixed with photoinitiator and cross-linked with ultraviolet 
light (Jeon et al, 2009; Cha et al, 2009). 
The mechanical properties of alginate hydrogels can be controlled with the type and 
concentration of cross-linker, the concentration of alginate molecules, and the molecular weight 
of alginate molecules.  Increasing the concentration of alginate molecules yields stiffer gels but 
also increases the viscosity of the pre-gelled solution which may be undesirable, especially for 
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cell encapsulation in which an increase in solution viscosity will lead to increased shear stresses 
on the cells and decreased cell viability (Augst et al, 2006).  To increase the stiffness of alginate 
hydrogels without significantly increasing the viscosity of the pre-gel solution, low molecular 
alginate can be used.  Low molecular weight alginate allows the viability of cells to be 
maintained during encapsulation despite increases in alginate concentration and subsequent 
hydrogel stiffness (Kong et al, 2003).  Furthermore, by varying the ratio between high molecular 
weight and low molecular weight alginate, the viscosity of the pre-gel solution can be decoupled 
from the stiffness of the resulting alginate hydrogels (Kong et al, 2002).  Incorporation of 
alginate modified with methacrylic groups has also been shown to control the mechanical 
properties of other hydrogel systems, including poly(ethylene glycol) diacrylate (PEGDA) and 
polyacrylamide (Jeong et al, 2011). 
The degradation properties of alginate hydrogels can be controlled with the molecular 
weight of alginate molecules or chemical modifications to the alginate backbone.  Ionically 
cross-linked alginate hydrogels will dissolve in neutral pH as the divalent cross-linkers diffuse 
(Augst et al, 2006).  For more controlled degradation, the molecular weight distribution of the 
pre-gel solution can be controlled.  Incorporation of low molecular weight alginate increases the 
degradation kinetics of alginate hydrogels (Kong et al, 2004).  In addition, the alginate backbone 
can be oxidized with sodium periodate to expose hydrolytically labile bonds (Boontheekul et al, 
2005).  Further modification of the oxidized alginate with methacrylic groups can be used to 
control degradation behavior of other hydrogel systems, including PEGDA, and facilitate the 
reorganization of encapsulated cells (Zorlutuna et al, 2011). 
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1.1.1.2 Poly(ethylene glycol) 
Poly(ethylene glycol) (PEG) is a variation of poly(ethylene oxide) (PEO), which is one of 
the most common synthetic polymers used in tissue engineering.  Due to its biocompatibility and 
low toxicity, PEO has been approved by the Food and Drug Administration (FDA) for several 
medical applications.  PEO is an extremely hydrophilic polymer and can be chemically modified 
to contain enzymatically-cleavable or hydrolytically-degradable sequences.  It has also been 
modified to contain acrylate groups so hydrogels can be formed through photopolymerization.   
PEG is a biocompatible, inert, hydrophilic polymer.  PEG hydrogels are frequently 
formed from photopolymerizations of acrylate-terminated PEG monomers (Peppas et al, 2006).  
Photopolymerizable PEG has been used in various applications including cell encapsulation and 
drug delivery (Ifkovits and Burdick, 2007).  In order to promote cell spreading on and within 
PEG hydrogels, researchers have modified RGD cell adhesion peptides with acrylate moieties 
for incorporation into PEG diacrylate hydrogels (Hern and Hubbell, 1997; Burdick and Anseth, 
2002).  Degradable linkages can be incorporated in the PEG backbone to yield degradable PEG 
hydrogels.  For example, α-hydroxy acid oligomers have been incorporated in between the PEG 
and photoreactive groups to yield hydrolytically degradable PEG chains (Sawhney et al, 1993).  
Using a similar strategy, proteolytically degradable groups have also been incorporated in the 
PEG backbone to facilitate degradation (West and Hubbell, 1999). 
 
1.1.2 Stem cells in tissue engineering 
One of the significant challenges in the field of tissue engineering has been finding viable 
cell sources.  Stem cells have the ability to differentiate into specific cell types or lineages, and 
this pluripotent nature of stem cells makes them attractive for tissue regeneration applications 
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(Khademhosseini et al, 2006; Badylak and Nerem, 2010).  Adult stem cells can be isolated from 
various tissues in the body, including bone marrow and fat tissue.  Embryonic stem cells (ESCs), 
isolated from the inner cell mass of a developing blastocyst, are capable of differentiating into 
any cell type, but the use of ESCs has been hindered by poor controllability of self-renewal and 
differentiation as well as ethical concerns.  For stem cells to be used effectively in tissue 
engineering, the necessary number of cells with the appropriate phenotype must be obtained 
(Mikos et al, 2006; Polak and Bishop, 2006).  Towards this end, stem cell niches are being 
extensively studied in efforts to develop synthetic stem cell niches to control the proliferation 
and differentiation of stem cells (Lutolf and Blau, 2009). 
Separately, much research is focused on identifying, purifying, and expanding adult stem 
cell populations for tissue engineering applications (Lutolf and Blau, 2009).  Hematopoietic stem 
cells (HSCs) are multipotent cells that can give rise to all the cell types found in blood.  HSCs 
have also been shown to differentiate into liver cells (Lagasse 2000).  Stem cells isolated from 
blood have been shown to undergo osteogenic differentiation (Kuznetsov et al, 2001). 
Endothelial progenitor cells (EPCs), which are isolated from peripheral blood or cord blood, 
have been investigated for vascular tissue engineering applications (Riha et al, 2005). 
Mesenchymal stem cells (MSCs) are another population of adult stem cells that have 
been widely used in tissue engineering due to their potential to differentiate into mesenchymal 
tissues, including bone, ligament, cartilage, and muscle.  For vascular engineering, MSCs can be 
differentiated into smooth muscle and endothelial cell types to engineer new blood vessels (Riha 
et al, 2005).  For bone tissue engineering, researchers have combined MSCs with biomaterial 
scaffolds that can be implanted in bone defects to promote tissue regeneration and defect repair.  
This approach has been shown to improve bone formation in vivo, and it has been proposed that 
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the therapeutic effects of implanted MSCs are related both to an increased number of progenitor 
cells and also osteogenic factors secreted by the cells.  MSCs can also be cultured within 
biomaterial scaffolds in vitro to promote osteogenic differentiation and bone formation prior to 
implantation in vivo.  In addition, MSCs have been transplanted without the use of biomaterial 
scaffolds to treat musculoskeletal diseases such as osteoporosis.  Despite promising results, the 
use of MSCs has been limited by difficulties in expanding MSCs to clinically useful numbers 
while maintaining their differentiation potential (Mauney et al, 2005). 
 
1.2 Synthetic extracellular matrices 
The extracellular matrix (ECM) is a major component of cellular microenvironments, 
which also consist of surrounding cells and soluble factors.  Crosstalk between the extracellular 
matrix and the cell cytoskeleton has been shown to regulate cell behavior including migration, 
morphogenesis, proliferation, differentiation, and death (Lutolf and Hubbell, 2005).  Cells attach 
to the surrounding matrix through integrins which interact with the actin cytoskeleton in the cell 
interior.  Focal adhesions are the most well-characterized cell-matrix adhesions and are located 
near the periphery of cells (Geiger et al, 2001).  For stem cells, the cellular microenvironment is 
also known as a stem cell niche, and the surrounding ECM is involved in stem cell proliferation 
and differentiation (Lutolf and Blau, 2009). 
Synthetic ECMs have been synthesized to direct cellular behavior and function and also 
to study cell-matrix interactions in vitro in efforts to gain a better understanding of the 
interactions between cells and their microenvironments.  Naturally-derived hydrogel polymers 
are well-suited for use as synthetic ECMs due to their similarity to the native ECM.  While 
useful in clinical applications, naturally-derived polymers exhibit poor controllability and are 
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thus not well-suited for scientific studies to investigate cell-matrix interactions.  Synthetic 
materials can be modified to mimic the natural ECM and frequently allow for more 
controllability than naturally-derived polymers.  In order to serve as ECMs, synthetic materials 
must be modified with the appropriate biological cues, including cell adhesion domains for 
integrin binding.  Additional bioactive domains may also be needed, including binding sites for 
growth factors and enzymatically-degradable sequences (Lutolf and Hubbell, 2005). 
Synthetic ECMs can be designed to support cells in two-dimensional (2D) or three-
dimensional (3D) cultures.  To more accurately mimic the natural ECM, much research is 
currently focused on developing 3D synthetic ECMs (Lutolf and Hubbell, 2005; Griffith and 
Swartz, 2006).  Synthetic ECMs have also been considered for use in testing molecular 
therapeutics.  In vitro testing of molecular therapeutics has often been a poor predictor of in vivo 
responses, possibly due to differences in the cellular microenvironment between in vitro and in 
vivo conditions (Bhadriraju and Chen, 2002).  Changes in the cellular microenvironment have 
been shown to alter the cellular response to molecular therapeutics, and the properties and 
structure of the ECM are known to change with disease and trauma (Kong and Mooney, 2007).  
Synthetic ECMs with tunable properties would thus be useful for in vitro testing of molecular 
therapeutics.  Overall, much research has been focused on the design and development of 
synthetic ECMs with particular emphasis on the effects of stiffness and cell adhesion ligands 
presented by synthetic ECMs. 
 
1.2.1 Effects of matrix stiffness on cell behavior 
The stiffness of a material can be measured with its elastic modulus, which quantifies the 
tendency of a material to deform upon application of an external stress.  More specifically, the 
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elastic modulus is defined as the slope of the stress-strain curve of a material upon elastic 
deformation.  Tissues in the body span a wide range of elastic moduli; for example, brain tissue 
has an elastic modulus around 1 kPa while collagenous bone has an elastic modulus around 100 
kPa.  Cells are able to sense and respond to ECM stiffness by pulling on and deforming the 
matrix.  Matrix stiffness has been shown to influence a wide range of cell behavior, including 
contractility, motility, and spreading (Discher et al, 2005).  
The effects of matrix stiffness on cell behavior were first demonstrated using epithelial 
cells and fibroblasts cultured on collagen-coated polyacrylamide hydrogels (Pelham and Wang, 
1997).  Since then, much research has been focused on the effects of matrix stiffness on various 
cell behavior and function.  The proliferation and differentiation of preosteoblasts were regulated 
by substrate stiffness, as cells exhibited increased proliferation and decreased differentiation 
when cultured on gels of increasing stiffness (Kong et al, 2005).  Substrate stiffness was also 
shown to influence preosteoblast migration, focal adhesion formation, and cytoskeletal 
organization (Khatiwala et al, 2006).  Mesenchymal stem cells have been shown to differentiate 
to various lineages based on the stiffness of the substrate on which they are cultured (Engler et 
al, 2006).  Substrate stiffness has also been shown to influence cell spreading, actin cytoskeleton 
formation and integrin expression (Yeung et al, 2005). 
 
1.2.2 Effects of cell adhesion cues on cell behavior 
Interactions between cells and their surrounding ECM are governed by cell-matrix 
binding through integrins on the cell surface.  These cell-matrix binding interactions influence 
intracellular signaling and gene expression, thus controlling cell function.  Synthetic ECMs with 
varied density, spacing, and conformation of cell adhesion ligands have been used in efforts to 
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better understand these cell-matrix binding interactions that are known to influence various cell 
processes (Kong et al, 2006). 
The density of cell adhesion peptides incorporated in synthetic ECMs was shown to 
influence the proliferation and differentiation of myoblasts cultured on a 2D synthetic ECM 
(Rowley and Mooney, 2002) as well as the proliferation and differentiation of pre-osteoblasts 
and myoblasts cultured within a 3D synthetic ECM (Kong et al, 2006).  The proliferation and 
differentiation of pre-osteoblasts cultured on hydrogel substrates were increased by decreasing 
the spacing of cell adhesion ligands in the synthetic ECM (Lee et al, 2004).  Furthermore, the 
spacing of cell adhesion ligands incorporated in synthetic ECMs influenced integrin-ligand bond 
formation for cells cultured on 2D while having little effect on integrin-ligand bond formation 
for cells cultured in a 3D synthetic ECM (Hsiong et al, 2008).  The conformation of cell 
adhesion peptides in synthetic ECMs has also been shown to influence cell behavior (Hsiong et 
al, 2009).   
 
1.3 Gene therapy 
Gene therapy refers to the transfer of genetic material in efforts to treat disease (Glover et 
al, 2005; Pack et al, 2005).  Gene therapy can be used to replace defective genes in the treatment 
of genetic diseases, such as cystic fibrosis, haemophilia, or muscular dystrophy, or be used to 
deliver therapeutic proteins in the treatment of acquired diseases, such as cancer or 
cardiovascular disease (Pack et al 2005; Edelstein et al, 2007).  In tissue engineering 
applications, therapeutic genes can be delivered in efforts to repair lost or damaged tissues 
(Storrie and Mooney, 2006; De Laporte and Shea, 2007; O’Rorke et al, 2010).  The success of 
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gene therapy depends on safely delivering the appropriate genes to target cells to induce the 
necessary expression profiles and ultimately achieve therapeutic efficacy (Pack et al, 2005).
 
 
1.3.1 Delivery of therapeutic genes 
Gene delivery vectors are used to package therapeutic genes for delivery to host cells and 
can generally be classified as viral or non-viral vectors (Pack et al, 2005).  Due to safety 
concerns associated with viral vectors, including immunogenicity and mutagenesis resulting 
from insertions of the viral genome into the genome of the host cell (Glover et al, 2005), much 
research has focused on the use of non-viral vectors for gene delivery.  The majority of non-viral 
vectors have been synthesized from lipids, polymers, or polypeptides.  These materials typically 
contain cationic groups that electrostatically bind to and condense genes to form polyplexes, 
which protect the genes and facilitate their entry to target cells.  Poly(ethyleneimine) (PEI) is a 
widely used polymer for non-viral gene delivery.  Unfortunately, the use of non-viral vectors has 
thus far been limited by low gene-transfer efficiencies in vivo (Pack et al, 2005). 
Therapeutic genes can be delivered to the body through a variety of administration routes 
including intramuscular injection, intravenous injection, and subcutaneous administration 
(Pouton et al, 2001; Herweijer and Wolff, 2003).  Delivered genes must first overcome a variety 
of extracellular and intracellular barriers before expression by target cells can be achieved.  In 
the bloodstream, the majority of delivered genes are quickly cleared through the liver or 
degraded by plasma nucleases before reaching the target cells.  Targeting the appropriate host 
cells may be another hurdle, and much research has focused on conjugating targeting cues to 
gene delivery vectors for increased cell-specificity.  Once the polyplex has reached the cells, the 
complex must be internalized, typically through endocytosis.  The polyplex must then escape the 
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endosome, transport through the cytoplasm, and enter the nucleus to begin transcription.  In 
order for the gene to be expressed, it must also be unpackaged from the delivery vehicle after 
entry into the cell.  These barriers are not insignificant, as evidenced by low expression 
efficiency despite high gene uptake.  Low gene transfer efficiency in vivo is one of the major 
hurdles to effective non-viral gene delivery for therapeutic applications (Pack et al, 2005; 
Wiethoff and Middaugh, 2003).  In efforts to improve gene transfer efficiency, much research 
has been focused on designing and synthesizing gene delivery vectors (Leong at al, 1998; 
Fischer et al, 1999; Forrest et al, 2003; Mintzer and Simanek 2003). 
 
1.3.2 Gene therapy in tissue engineering 
Tissue engineering strategies typically require the use of cytokines or growth factors to 
stimulate tissue regeneration.  Direct protein delivery, however, is problematic due to issues such 
as limited protein stability.  Gene delivery is an attractive alternative to protein delivery for tissue 
engineering applications, as genes can be used to stimulate therapeutic protein production.  For 
tissue engineering, both viral and non-viral vectors have been used with varying success.  As 
with all gene therapies, one of the challenges to using therapeutic genes in tissue engineering is 
activating target cells to express the needed amount of therapeutic protein for the appropriate 
duration (Heyde et al, 2007).  For tissue regeneration, growth factor signaling is typically desired 
only at the defect site and typically required for only a few weeks (Storrie and Mooney, 2006). 
For tissue engineering applications, therapeutic genes can be delivered in vivo or ex vivo.  
In vivo delivery refers to the delivery of therapeutic genes directly to the body, typically at the 
site of interest.  The genes can either be directly injected to the target site or encapsulated in a 
scaffold for implantation at the target site.  In the latter strategy, the scaffold can serve as a 
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delivery depot while protecting the encapsulated genes from degradation.  For ex vivo delivery, 
cells, which can be isolated from the patient, are transfected with the therapeutic gene in vitro 
and then transplanted at the site of interest.  Transfected cells can be delivered by direct injection 
or incorporated in biomaterial scaffolds for transplantation (Heyde et al, 2007). 
Much research has focused on the use of biomaterial scaffolds as gene delivery depots for 
tissue engineering applications (Storrie and Mooney, 2006).  Genes can be incorporated into 
polymer scaffolds with or without delivery vectors; for example, plasmid DNA can either be 
incorporated directly into a scaffold or condensed with a cationic polymer prior to incorporation.  
Gene delivery vectors can be physically immobilized in the hydrogel scaffold through non-
specific binding, such as van der Waals, hydrophobic, or electrostatic interactions, or through 
chemical coupling.  Vectors that interact with the scaffold through non-specific binding can be 
released through desorption while vectors that are chemically linked to the scaffold are released 
upon degradation of the linkage (De Laporte and Shea 2007). 
Another critical issue in gene delivery is the effect of the cellular microenvironment 
(Kong and Mooney, 2007).  Recent studies have shown that matrix stiffness plays a role in 
regulating non-viral gene delivery.  Pre-osteoblasts cultured on hydrogel-based cell adhesion 
substrates demonstrated an increase in the uptake and expression of plasmid DNA as the stiffness 
of the substrates was increased (Kong et al, 2005).  In addition to substrate stiffness, the density 
and spacing of cell adhesion ligands has been shown to influence non-viral gene delivery.  Gene 
transfer to and subsequent expression from pre-osteoblasts cultured on hydrogel-based cell 
adhesion substrates increased as the density of cell adhesion ligands was increased and the 
spacing of cell adhesion ligands was decreased (Kong et al, 2006).  
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1.4 Project overview 
The work described in this thesis focuses on the development of synthetic ECMs for stem 
cell culture and gene delivery.  Overall, the objective of this work was to evaluate design 
parameters for synthetic ECMs to facilitate the use of stem cells and therapeutic genes for tissue 
engineering applications.  First, in Chapter 2, the development of a synthetic stem cell niche for 
spermatogonial stem cell culture (SSC) will be described.  The subsequent two chapters, 
Chapters 3 and 4, focus on designing synthetic ECMs for gene delivery.  The effects of matrix 
stiffness on non-viral gene delivery to fibroblasts, bone marrow stromal cells (BMSCs), and 
myoblasts will be outlined followed by the development of a synthetic ECM with angiogenic 
gene therapy for revascularization.  Ultimately, the results from these studies will be useful for 
developing advanced tissue engineering strategies for clinical settings. 
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CHAPTER 2:  THREE-DIMENSIONAL SYNTHETIC NICHE FOR 
SPERMATOGONIAL STEM CELL CULTURE
*
 
 
 
 
2.1 Introduction 
 The use of stem cells in efforts to repair tissues and organs has become increasingly 
prevalent in the field of tissue engineering.  Stem cells reside in specialized microenvironments, 
or niches, which regulate their self-renewal and overall maintenance (Schofield, 1978; Watt and 
Hogan, 2000).  In order to best utilize the therapeutic potential of stem cells, it is crucial to 
understand the interactions between stem cells and their native environment to define optimal 
niches for therapeutic applications (Gumbiner, 1996; Griffith and Swartz, 2006).  Significant 
progress has been made in characterizing the niche microenvironment of a variety of stem cells; 
more specifically, recent studies have investigated the hematopoietic, epidermal, intestinal, and 
neural stem cell niches (Li and Xie, 2005; Moore and Lemischka, 2006).  Within each niche, 
supporting cells and associated blood vessels produce the necessary growth factors and stimuli 
that will modulate stem cell behavior.  In addition, the extracellular matrix (ECM) is responsible 
for cell attachment and can also regulate cellular response to surrounding stimuli (Discher et al, 
2005; Geiger et al, 2001).  Therefore, the composition of the ECM and the interactions between 
cells and their surrounding matrix are crucial in regulating stem cell fate. 
Stem cells belonging to epithelial structures generally reside on a specialized ECM called 
the basement membrane. Although composed of a small set of specific proteins such as collagen 
IV, laminin, entactin, fibronectin and perlecan, the basement membrane shows an impressive 
                                                 
*
 This chapter contains work previously published in Tissue Engineering and is reprinted here with the permission of 
Mary Ann Liebert, Inc.  This work was previously published as Chu C, Schmidt JJ, Carnes K, Zhang Z, Kong HJ, 
Hofmann MC.  Three-dimensional synthetic niche components to control germ cell proliferation.  Tissue 
Engineering 15, 255, 2009. 
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tissue- and site-specific variability in its composition (McMillan et al, 2003).  Maintenance of 
stemness, proliferation, and migration take place in the basal layer of epithelia, in contact with 
the basement membrane.  These biological activities are regulated in part through interactions 
between individual components of the basement membrane and cell surface receptors called 
integrins (Giancotti and Ruoslahti, 1999; Erickson and Couchman, 2000).  Integrins recognize 
and bind various ECM proteins, including those that contain the Arg-Gly-Asp (RGD) peptide 
sequence (Pierschbacher and Ruoslahti, 1984; Gardner and Hynes, 1985). 
Biomaterials have been increasingly used to simulate and even modulate cell adhesion to 
the ECM in order to regulate signaling pathways controlling cell function and tissue 
morphogenesis.  For this purpose, biomaterials have been designed to mimic the biochemical and 
biomechanical properties of the natural ECM (Lee and Mooney, 2001; Luotlf and Hubbell, 2005; 
Stevens and George, 2005).  Extensive chemical modifications have been used to incorporate 
synthetic cell adhesion oligopeptides into biomaterials, and the spatial organization of these cell 
adhesion cues at the nanometer and micrometer scale has been used to modulate the function of 
progenitor and precursor cells (Rowley and Mooney, 2002; Lee et al, 2004; Kong et al, 2005; 
Kong et al, 2007).  In addition, the mechanical stiffness of biomaterials to which cells are 
adhered has been shown to significantly regulate the phenotypes of precursor cells (Kong et al, 
2006; Boontheekul et al, 2007). 
Mammalian spermatogenesis is a tightly regulated and continuous process in which 
spermatogonial stem cells (SSCs) self-renew and differentiate to ultimately form spermatozoa.  
The SSC niche is found within the seminiferous epithelium where nursing Sertoli cells provide 
structural support and growth factors to the stem cells.  Other stimuli are provided by the 
vascular network and interstitial cells between the seminiferous tubules (Yoshida et al, 2007).  
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Another important component of the testicular niche is the basement membrane, to which stem 
cells and Sertoli cells are attached through integrins.  In 2004, the group of T. Shinohara 
demonstrated that mouse SSCs can dedifferentiate in vitro, reverting into cells that acquire an ES 
cell phenotype (Kanatsu-Shinohara et al, 2004).  These ES-like cells can then be differentiated 
into cells belonging to the three embryonic germ layers.  More recently, the same potential for 
pluripotency has been demonstrated for adult SSCs (Guan et al, 2006).  Therefore, SSCs could 
potentially be used to regenerate and engineer specific tissues in an autologous manner.  While 
progress has been made recently in expanding SSCs in vitro using cocktails of growth factors 
(Kubota et al, 2004; Kanatsu-Shinohara et al, 2005), growing and maintaining these cells in vitro 
can be further optimized. Therefore, other niche parameters that are important for SSC 
proliferation in vitro, specifically the composition of the extracellular matrix, need to be 
characterized. 
 
2.2  Objective and scope 
 In the present study, we hypothesize that a bioactive hydrogel designed to mimic some of 
the biochemical and biomechanical properties of the basement membrane can be used as part of 
a synthetic niche; by mimicking the in vivo niche, such a synthetic niche can be used to regulate 
SSC proliferation.  This study presents an initial set of parameters that has been known to 
significantly regulate the phenotypes of precursor cells, namely cell adhesion ligand density and 
mechanical properties.  Calcium cross-linked alginate hydrogels, which do not naturally facilitate 
protein absorption and cell adhesion (Smetana, 1993; Rowley et al, 1999) were chemically 
coupled with synthetic oligopeptides containing the Arg-Gly-Asp (RGD) sequence (RGD 
peptides) in order to control the number of cell adhesion sites for a spermatogonial stem cell line.  
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As a model for SSCs, the C18-4 spermatogonial cell line was used (Hofmann et al, 2005).  This 
cell line exhibits many of the characteristics of normal spermatogonial stem cells, including the 
expression of the GFR-1/Ret membrane receptor complex that binds the growth factor glial cell 
line-derived neurotrophic factor (GDNF). Upon stimulation with GDNF, the cells increase their 
rate of proliferation, which is mediated by Src and Ras-dependent signaling pathways (Braydich-
Stolle et al, 2007; He et al, 2008).  The mechanical stiffness of the hydrogels was varied from 8 – 
110 kPa, which is within the stiffness range of the natural basement membrane (Lu et al, 2004; 
Candiello et al, 2007), to examine the effects of matrix stiffness on SSC behavior.  The hydrogel 
properties were first optimized through cell culture on two-dimensional (2D) hydrogel surfaces; 
cell adhesion and proliferation were then subsequently examined in three-dimensional (3D) 
hydrogel systems. 
 
2.3  Materials and methods 
2.3.1  Alginate modification 
Sodium alginate (FMC Biopolymer, Philadelphia, PA) was used as high molecular 
weight alginate (Mw ~ 250,000 g/mol).  Low molecular weight alginate (Mw ~ 60,000 g/mol) was 
obtained by irradiating the sodium alginate with a cobalt-60 source for 4 hours at a dose of 5.0 
Mrad (Kong et al, 2002).  Alginate molecules were covalently coupled with (Gly)4-Arg-Gly-
Asp-Ala-Ser-Ser-Lys (G4RGDASSKY) oligopeptides (Peptides International, Louisville, KY) 
using a carbodiimide chemistry as previously described (Figure 2.1; Rowley et al, 1999).  The 
mole ratio between RGD peptides and alginate was kept constant at 2:1.  All alginate solutions 
were filtered, lyophilized, and reconstituted with Dulbecco's Modified Eagle’s Medium (DMEM, 
Invitrogen Corporation, Carlsbad, CA) to obtain a 2% w/v solution prior to gelation. 
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2.3.2  Cell line and cell culture 
The C18-4 cell line was established by stably transfecting undifferentiated type A 
spematogonia with the Large T antigen gene driven by the ecdysone promoter (Hofmann et al, 
2005).  These cells exhibit many features of spermatogonial stem cells, including the expression 
of Oct-4, Vasa, and the receptor complex for glial cell line-derived neurotrophic factor (GDNF), 
a crucial stimulus for self-renewal (Braydich-Stolle et al, 2007; He et al, 2008).  Cells were 
cultured in DMEM supplemented with 10% fetal bovine serum (FBS, Invitrogen Corporation, 
Calrsbad, CA) and 100 units/ml penicillin-streptomycin (Invitrogen Corporation, Carlsbad, CA) 
at 37° C in a 5% CO2 incubator.  The cell culture medium was changed every other day. 
 
2.3.3  Two-dimensional cell culture on hydrogels 
High molecular weight alginate was used for two-dimensional (2D) cell culture studies.  
Gels with 3 different densities of cell adhesion peptides were made by mixing unmodified high 
molecular weight alginate with G4RGDASSKY-conjugated high molecular weight alginate in 
ratios of 9:1, 1:1, and 1:9.  Alginate hydrogels were formed with ionic cross-linking (Figure 2.2) 
by mixing alginate solutions with a 20% (w/w) calcium sulfate (CaSO4, Sigma Aldrich, St. 
Louis, MO) slurry at a ratio of 40 µl CaSO4 slurry to 1 ml alginate solution and allowed to gel 
between glass plates with a 1 mm spacer. 
For experiments to examine the effects of hydrogel stiffness on cell proliferation, both 
high molecular weight and low molecular weight alginate were used.  The ratio between CaSO4 
slurry and alginate was varied between 20 and 60 µl CaSO4 slurry to 1 ml high molecular weight 
alginate solution and 20 to 40 µl CaSO4 slurry to 1 ml low molecular weight alginate.  Gel disks 
were punched using a 5 mm diameter puncher and incubated in DMEM for 36 hours, changing 
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media every 12 hours.  The elastic modulus of the hydrogels were calculated from the slope of 
the compressive stress versus strain curve acquired using an MTS Insight Electromechanical 
Testing System.  Cells were seeded on the disks at a density of 640 cells/mm
2
 and incubated in 
complete growth media.  Media was changed every 48 hours thereafter.  
 
2.3.4  Three-dimensional cell culture in hydrogels 
Low molecular weight alginate was used for three-dimensional (3D) cell culture studies.  
Gels without RGD peptides were made from unmodified low molecular weight alginate.  Gels 
with RGD peptides were made by mixing unmodified low molecular weight alginate with 
G4RGDASSKY-conjugated low molecular weight alginate in 9:1, 1:1, and 1:9 ratios.  Cells were 
encapsulated in alginate gels at a density of 6 × 10
5
 cells/ml by mixing equal volumes of the cell 
suspension and an alginate solution.  The cell-alginate mixture was cross-linked with a CaSO4 
slurry at a ratio of 40 µl CaSO4 slurry to 1 ml cell-alginate mixture and allowed to gel between 
glass plates with a 1 mm spacer.  10 mm gel disks were punched and incubated in complete 
growth media.  Media was changed after 24 hours and every 48 hours thereafter. 
 
2.3.5  Analysis of stress fibers for 2D cultures 
After culture of cells on the hydrogel surfaces for 5 days, cell-hydrogel constructs were 
fixed overnight in a solution of 4% formaldehyde (Sigma Aldrich), washed with phosphate 
buffer saline (PBS, Invitrogen), and permeabilized with a solution of 0.5% Triton X-100 (Sigma 
Aldrich) and 5% dry milk. Intracellular actin stress fibers were stained using Oregon Green 514 
phalloidin (Invitrogen).  Oregon Green 514 phalloidin was diluted in PBS to 5 units/ml, and 1 ml 
was used to stain each gel for 30 minutes.  Gels were rinsed with 0.5% Triton X-100 and 5% dry 
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milk and then washed extensively in DMEM.  The stained gels were visualized using a Leica 
TCS SP2 confocal system. 
 
2.3.6  Cell proliferation assay for 2D cultures 
Cell numbers on the 2D gels were analyzed on Days 1, 3, and 5. Four disks for each 
condition on each day were used for analysis.  Four different micrographs were taken from 
random locations on each gel, and the total number of cells in each set of four micrographs was 
counted.  The cell counts were normalized to those counted on Day 1. 
 
2.3.7  Cell proliferation and viability assays for 3D cultures 
Cell proliferation in the 3D gels was analyzed with MTS tetrazolium [3-(4,5-
dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner 
salt] (Promega Corporation, Madison, WI).  Cells were treated with MTS, and viable cells were 
evaluated by the formation of a soluble formazan product.  The amount of formazan produced 
was quantified with absorbance at 490nm, and the quantity of formazan measured was directly 
proportional to the number of viable cells in culture.  
To visualize viable cells after 5 days of culture, the 3D cell-gel constructs were treated 
with tetrazolium MTT [3-(4,5-dimethylthiazolyl-2)-2, 5-diphenyltetrazolium bromide] (ATCC, 
Manassas, VA).  Viable cells were evaluated by the formation of an insoluble dark purple 
formazan resulting from the reduction of the MTT reagent in mitochondria of viable cells.  The 
treated cell-gel constructs were visualized using a Leica DMI 4000B microscope. 
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2.3.8  Immunohistochemistry analysis for 3D cultures 
 After 5 days of culture, the 3D cell-hydrogel constructs were fixed overnight in either 4% 
paraformaldehyde in PBS or 10% formaldehyde in PBS, both at pH 7.4.  The hydrogels were 
then dehydrated in ascending percentages of ethanol, cleared in xylene, and embedded in low 
temperature paraffin.  Sections were cut at a thickness of 5 µm and affixed to pretreated glass 
slides.  Slides were deparaffinized, hydrated, and boiled for 10 minutes in a microwave for 
antigen retrieval with 0.01 M citrate buffer, pH 6.0. Sections were incubated in the appropriate 
serum (10% normal goat or rabbit), followed by incubation with the primary antibody for 1 hour 
at 37 ºC.  Following a rinse with PBS, the sections were incubated with the appropriate biotin-
conjugated secondary antibody at room temperature for 1 hour, rinsed again, and incubated with 
ABC solution (Vector Laboratories, Burlingame, CA) for 30 minutes.  Sections were colorized 
with diaminobenzidine, counterstained with Mayer hematoxylin (Sigma Aldrich), dehydrated, 
and coverslipped.  Negative control sections were treated in an identical manner but were 
incubated with PBS instead of the primary antibody. Antibodies used were anti-rabbit 
DDX4/MVH Primordial Germ Cell Marker (VASA) and anti-rat c-Kit (Caltag Laboratories, 
Burlingame, CA).  Secondary antibodies used were a biotinylated goat anti-rabbit (DAKO USA, 
Carpinteria, CA) and a biotinylated goat anti-rat (Abcam, Cambridge, MA). 
 
2.3.9  Statistical analysis 
 Statistical significance between two data populations was evaluated using an unpaired, 
two-tailed Student’s t-test in Microsoft Excel.  Differences were considered statistically 
significant for p < 0.05.  Statistical significance among more than two data populations was 
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evaluated using a one-way analysis of variance (ANOVA) in Minitab.  Data populations were 
considered statistically similar for p > 0.1 
 
2.4  Results 
2.4.1  Effects of RGD peptide densities and hydrogel stiffness on cell proliferation in 2D cultures 
Hydrogels presenting different RGD peptide densities (NRGD) were prepared by altering 
the ratio between alginate molecules modified with RGD peptides and unmodified alginate 
molecules from 1:9 to 9:1 to vary NRGD from 6.2 to 56 × 10
7
 RGD/mm
2
.  The RGD concentration 
on the surface of the hydrogel was calculated from the degree of substitution of RGD peptides 
and the ratio between modified and unmodified alginate assuming an alginate molecule occupies 
the same volume as a hard sphere with a radius equal to the radius of gyration of an alginate 
molecule.  Changes in NRGD had minimal effects on the hydrogel stiffness and swelling ratio.  
The effects of NRGD on the morphology and cytoskeleton of cells adhered to the gel 
surface were investigated by evaluating the formation of actin stress fibers.  Increasing NRGD 
enhanced the formation of intracellular actin stress fibers, which were remodeled upon cellular 
contractility (Figure 2.3).  SSC colony formation was also enhanced with increasing NRGD 
(Figure 2.4) while cell spreading was maximized at an intermediate NRGD; for single cells, the 
average projected cell areas at 6.2, 31, and 56 × 10
7
 RGD/mm
2
 were 84, 1500, and 510 µm
2
, 
respectively. 
Cell proliferation on 2D hydrogel surfaces was significantly dependent on NRGD.  Each 
SSC seeded formed distinct colonies of daughter cells, and the number of cells in each colony 
increased with NRGD during five days of cell culture, qualitatively indicating an enhancement in 
cell proliferation with NRGD (Figure 2.5).  A quantitative analysis of cell number over time also 
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confirmed that increasing cell adhesion sites promoted cell proliferation (Figure 2.6).  The lowest 
NRGD (6.2 × 10
7
 RGD/mm
2
) showed a minimal increase in cell number, and the difference 
between normalized cell numbers for the lowest and highest NRGD at Day 5 was statistically 
significant.  The cell proliferation rate (k) was further quantified from Eq 1:  
kt
N
N
2
0
                                                             Eq. 1 
where N represents the number of cells measured at a given time, N0 represents the initial 
number of cells measured at Day 1, and t represents the cell culture period.  The calculated k 
increased as NRGD increased.  The cell doubling time calculated from k decreased significantly as 
NRGD was increased from 3.1 × 10
8
 to 5.6 × 10
8
 RGD/mm
2
 (Figure 2.7). 
 In contrast, the stiffness of hydrogels played a minimal role in regulating cell 
proliferation.  A quantitative analysis of cell number over time showed that at a constant NRGD of 
6.2 × 10
8
 RGD/mm
2
, changes in the elastic modulus did not significantly alter the extent of cell 
spreading, the number of cells per colony, or the overall cell numbers (Figure 2.8).  The k values 
quantified using Eq 1 were statistically similar on hydrogels of different stiffness, indicating that 
k was roughly independent of the elastic modulus (Figure 2.9).  
 
2.4.2  Effects of RGD peptide densities on cell proliferation in 3D cultures 
Based on the results from cell proliferation on 2D gel surfaces, SSCs were encapsulated 
within four hydrogel formulations: unmodified alginate and alginate modified with RGD 
peptides at an NRGD of 1.5, 7.3, and 13 × 10
12
 RGD/mm
3
 in order to confirm the critical roles of 
cell adhesion peptides on cell proliferation in 3D cultures.  Low molecular weight alginate 
molecules were used for cell encapsulation in order to circumvent a loss of cell viability during 
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the encapsulation process (Kong et al, 2003).  The elastic moduli of the gels were kept constant 
at 15 kPa since cell proliferation was not dependent on hydrogel stiffness in 2D cell culture. 
Cell viability was evaluated by identifying viable cells with an MTT assay.  The MTT 
reagent was reduced to an insoluble dark purple formazan in the mitochondria of living cells, 
thus allowing viable cells to be identified with a dark stain.  Increasing NRGD from 0 to 1.3 × 10
13
 
RGD/mm
3
 increased the number of viable colonies; furthermore, cells encapsulated within 
hydrogels modified with RGD were mostly viable after five days in culture as compared with 
cells encapsulated within unmodified hydrogels (Figure 2.10).  Increasing NRGD from 0 to 1.3 × 
10
13
 RGD/mm
3
 also resulted in an increase in the diameter of viable colonies (Figure 2.11). 
Cell proliferation was evaluated with an MTS-based cell proliferation assay.  Formazan 
produced by viable cells in the reduction of MTS was detected with absorbance at 490 nm.  The 
measured absorbance, which was directly proportional to the number of viable cells, increased 
significantly with NRGD (Figure 2.12).  The cell proliferation rate (k) quantified using Eq 1 also 
increased with NRGD (Figure 2.13).  Gels with no RGD peptides resulted in negative k values, 
likely due to significant cell death. 
The integrity of the SSCs cultured within hydrogels modified with RGD peptides was 
further examined.  The expression of Vasa, a marker for undifferentiated SSCs, and c-kit, a 
marker for differentiating SSCs, were probed via immunostaining.  Cells cultured within 
hydrogels modified with RGD peptides were positively stained for Vasa (Figure 2.14A and 
2.14D) and negatively stained for c-kit (Figure 2.14B and 2.14E), indicating that the cells 
retained their undifferentiated germ cell properties.  In the unmodified hydrogels, which did not 
contain RGD, cells did not proliferate and died after five days in culture; therefore, their 
phenotype could not be analyzed (data not shown).  At an NRGD of 1.5 and 7.3 × 10
12
 RGD/mm
3
, 
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cells proliferated but the size of the colonies remained small (Figure 2.14A-C).  In comparison, 
colony sizes doubled with cells cultured at an NRGD of 1.3 × 10
13
 RGD/mm
3
 (Figure 2.14D-F).  
While NRGD influenced the size of cell colonies, it did not affect Vasa or c-kit expression. 
 
2.5  Discussion 
This study uses an advanced 3D cell culture system, which mimics some of the 
biochemical and biomechanical components of the basement membrane, to support SSC 
proliferation.  The culture system used in this study consisted of a bioactive hydrogel presenting 
cell adhesion molecules (RGD peptides) and was tested with varying cell adhesion sites and 
stiffness.  Interestingly, SSC proliferation could be regulated both in 2D and 3D cell cultures 
solely by altering hydrogel properties, without the addition of GDNF or other exogenous soluble 
factors.   
The proliferation rates of SSCs and adhesion to the gel matrix were significantly 
dependent on the density of RGD peptides.  In 2D cultures, the number of RGD peptides 
contributed to increasing the number of intracellular stress fibers but did not control the extent of 
SSC spreading.  In 3D cultures, the number of RGD peptides contributed to the formation of 
viable cell colonies.  It is likely that an increase in RGD peptide density led to an increase in the 
number of bonds between cellular integrins and RGD peptides, as previously examined (Kong et 
al, 2006).  This increase in bond number promoted focal adhesion formation at the cell adhesion 
sites and subsequent intracellular stress fiber formation.  It has been reported that this 
intracellular cytoskeletal reorganization influences the signaling pathways for cell division in 
both 2D and 3D cell culture (Margadant et al, 2007).  SSCs prominently express 61 integrins, 
which are known to bind to laminin in the basement membrane, and laminin is known to be 
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important in the maintenance of stem cells in general (Shinohara et al, 1999).  The fact that RGD 
modulates SSC proliferation in vitro implies either that the RGD on the  chain of laminin is 
important for SSC biology, or/and that other basement membrane proteins containing RGD play 
a role in SSC biology (Tashiro et al, 1991). 
In contrast, SSC proliferation was not influenced by mechanical stiffness of the 
hydrogels. Previous studies have demonstrated that the mechanical stiffness of hydrogels plays a 
critical role in regulating the proliferation of pre-osteoblast cells but a minimal role in regulating 
the proliferation of bone marrow-derived stem cells (Hsiong et al, 2007).  Previous studies have 
also demonstrated that mechanical stiffness plays a role in regulating the differentiation of both 
stem and precursor cells (Engler et al, 2006).  The lack of dependency of SSC proliferation on 
hydrogel stiffness is thus similar to the response of bone marrow-derived stem cells.  This result 
may be due to the lack of intrinsic factors in SSCs which respond to mechanical stress, in 
comparison to more differentiated cells or cells belonging to other lineages, such as pre-
osteoblasts.  
Overall, this study demonstrates that a bioactive hydrogel modified with synthetic 
oligopeptides can be highly useful in controlling SSC proliferation in both 2D and 3D cell 
culture by mimicking some of the biochemical properties of the basement membrane underlying 
the seminiferous epithelium.  In addition, the results of this study identified a key ECM variable 
that might regulate the proliferation of primary SSCs in the natural stem cell niche.  The 
differentiation of primary SSCs into specific lineages may regulated with the appropriate soluble 
factors for cells cultured within the hydrogel or for cells isolated from the hydrogel.  Therefore, 
the hydrogel system used in this study presents strong potential for use as a primary SSC 
transplantation vehicle in various cell-based therapies.  In addition, the crucial role of natural 
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stem cell niches in regulating stem cell activities can be further clarified using this synthetic 
hydrogel system.  Therefore, the results of this study would be broadly applicable to 
understanding the interactions between various stem cells and their microenvironments and 
ultimately controlling the diverse activities of a broad array of stem cells. 
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2.7 Figures 
 
Figure 2.1  RGD-alginate synthesis.  Arg-Gly-Asp (RGD) peptides were conjugated to alginate using carbodiimide 
chemistry. 
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Figure 2.2  Alginate hydrogel formation.  Alginate solutions were ionically cross-linked with a calcium sulfate 
slurry.  Multivalent cations, such as Ca
2+
, are known to cross-link the G blocks in alginate. 
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Figure 2.3  Effect of NRGD on SSC actin stress fiber formation in 2D.  The overall density of RGD peptides 
immobilized on hydrogel surfaces (NRGD) influenced cellular contractility.  Intracellular actin stress fiber formation 
was visibly enhanced as NRGD was increased.  (A), (B), and (C) represent C18-4 cells attached to gels presenting 
NRGD of 6.2, 31, and 56 × 10
7
 RGD/mm
2
, respectively.  Green fluorescence in microphotographs represents actin 
fibers stained with Oregon Green 514 phalloidin.  Images were captured after five days of culture. 
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Figure 2.4  Effect of NRGD on SSC colony formation in 2D.  SSC colony formation on 2D surfaces was enhanced 
with increasing NRGD.  (A), (B), and (C) represent C18-4 cells attached to gels presenting NRGD of 6.2, 31, and 56 × 
10
7
 RGD/mm
2
, respectively. 
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Figure 2.5  Effect of NRGD on SSC colony size in 2D.  The overall density of RGD peptides immobilized on 
hydrogel surfaces (NRGD) influenced C18-4 colony formation.  The number of cells per colony increased as NRGD 
was increased from 31 × 10
7
 RGD/mm
2
 (A) to 56 × 10
7
 RGD/mm
2
 (B). Green fluorescence in microphotographs 
represents actin fibers stained with Oregon Green 514 phalloidin.  Images were captured after five days of culture. 
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Figure 2.6  Effect of NRGD on SSC cell number over time in 2D.  Cell proliferation on 2D hydrogel surfaces was 
regulated by the overall density of RGD peptides immobilized on hydrogel surfaces (NRGD).  The increase in cell 
number (N) over time was accelerated with NRGD.   N and N0 represent the cell number and the cell number measured 
at Day 1, respectively.  ●, ■, and ▲ represent NRGD of 6.2, 31, and 56 × 10
7
 RGD/mm
2
, respectively. Differences 
between N/N0 at Day 5 for the highest and lowest NRGD were statistically significant (*p<0.05). 
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Figure 2.7  Effects of NRGD on proliferation rate of SSCs in 2D.  The cell proliferation rate (k) increased with 
NRGD.  ● and ■ represent k and doubling time, respectively.  Differences between the calculated k values at the 
highest and lowest NRGD were statistically significant (*p<0.05).  Values represent the mean and standard deviation 
from four independent measurements. 
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Figure 2.8  Effects of substrate stiffness on SSC cell number over time in 2D.  Cell proliferation on 2D hydrogel 
surfaces was roughly independent of the elastic modulus of the hydrogel.  NRGD was kept constant at 6.2 x 10
8
 
RGD/mm
2
 while the elastic modulus was varied from 8 kPa to 110 kPa.  N and N0 represent the cell number and the 
cell number measured at Day 1, respectively.  ■, ●, ▲, □, and ○ represent gels with elastic moduli of 8, 20, 40, 60, 
and 110 kPa, respectively. 
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Figure 2.9  Effects of substrate stiffness on SSC proliferation.  The stiffness of hydrogels did not significantly 
influence C18-4 cell proliferation.  Cell proliferation rate (k) on 2D hydrogel surfaces, calculated from the increase 
in cell number over time, was roughly independent of the elastic modulus of the hydrogel (E).  NRGD was kept 
constant at 6.2 × 10
8
 RGD/mm
2
.  The calculated k values were statistically similar on gels of different stiffness, as 
determined with ANOVA.  Values represent the mean and standard deviation from four independent measurements. 
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Figure 2.10  Effect of NRGD on SSC colony formation in 3D.  The overall density of RGD peptides (NRGD) 
influenced C18-4 colony formation in 3D cultures.  Increasing NRGD from 0 (A) to 1.3 × 10
13
 RGD/mm
3
 (B) within a 
3D hydrogel matrix increased SSC colony formation. The number of viable cells positively stained with an MTT 
assay also increased with NRGD. In (A) and (B), viable SSC colonies positively stained with MTT are represented 
with asterisk (*), while nonviable cells, unstained with MTT, are circled. 
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Figure 2.11  Effect of NRGD on SSC colony size in 3D.  The overall density of RGD peptides (NRGD) influenced 
C18-4 colony formation in 3D cultures.  The average diameter of viable cell colonies increased with increasing 
NRGD.  Differences between average cell colony diameters in gels without RGD as compared to gels presenting RGD 
were statistically significant (*p<0.05). 
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Figure 2.12  Effect of NRGD on cell viability in 3D.  Cell viability in 3D hydrogel cultures on Day 5 increased with 
increasing RGD density.  The absorbance measured at 490nm, in accordance with an MTS-based proliferation 
assay, is proportional to the number of viable cells.  NRGD was varied from 0 to 1.3 × 10
13
 RGD/mm
3
. 
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Figure 2.13  Effect of NRGD on SSC proliferation in 3D.  The cell proliferation rate (k) of C18-4 cells cultured in 
3D increased with increasing NRGD.  Differences between calculated k values were statistically significant on gels 
with different NRGD, as determined with ANOVA. The elastic moduli of the hydrogels were kept constant at 15 kPa. 
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Figure 2.14  Immunocytochemistry analysis of SSC colonies in 3D.  Cells cultured in 3D hydrogels expressed 
Vasa but did not express c-Kit. NRGD was varied from 1.5 × 10
12
 RGD/mm
3
 (A–C) to 1.3 × 1013 RGD/mm3 (D–F).  
Cells expressed Vasa at all NRGD, as indicated with arrows (A and D). Cells did not express the c-Kit protein at any 
NRGD (B and E).  (C) and (F) represent negative controls, colonies stained without primary antibodies. 
  
52 
 
CHAPTER 3:  INTERPLAY OF CELL ADHESION MATRIX STIFFNESS AND CELL 
TYPE FOR NON-VIRAL GENE DELIVERY
*
 
 
 
3.1 Introduction 
Non-viral gene delivery has the potential to treat a wide array of diseases through the 
transfer of genetic material while circumventing safety concerns associated with viral vectors 
(Luo and Saltzman, 2000; Glover et al, 2005; Pack et al, 2005).  To facilitate entry to target cells, 
therapeutic genes are often packaged with delivery vectors, such as polycations, lipids, 
dendrimers, and virus-mimicking constructs (Putnam, 2006; Mintzer and Simanek, 2009).  The 
resulting polyplexes can be administered directly to the target tissue to induce exogenous 
expression in host cells or loaded into a provisional matrix for tissue regeneration (Storrie and 
Mooney, 2006; De Laporte and Shea 2007; O’Rorke et al, 2010).  While non-viral gene delivery 
holds much promise and has demonstrated impressive results, it still suffers from limited and 
inconsistent expression in vivo (Pack et al, 2005; Pouton and Seymour, 2001; Wiethoff and 
Middaugh 2003; rose et al, 2012). 
Several in vitro studies have recently reported that gene delivery to cells cultured on a 
synthetic extracellular matrix (ECM) can be regulated with chemical and mechanical properties 
of the matrix.  For example, gene transfection efficiency has been regulated by matrix stiffness 
(Kong et al, 2005) and cell adhesion domains (Kong et al, 2007; Dhaliwal et al, 2012) for cells 
cultured on synthetic substrates.  In these studies, the effects of matrix properties on gene 
delivery were attributed to changes in cellular proliferation rate affecting gene uptake as well as 
intracellular activities affecting gene expression. 
                                                 
*
 This chapter contains work accepted for publication in Acta Biomaterialia and is reprinted here with the 
permission of Elsevier. 
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Recent studies have also reported that the extent to which ECM properties influence 
cellular activities varies among cell types (Yeung et al, 2005; Georges and Janmey, 2005; 
Discher et al, 2005).  For example, the proliferation rate of bone precursor cells was shown to 
increase with increasing matrix stiffness while the proliferation rate of bone marrow stromal 
cells was less dependent on matrix stiffness (Hsiong et al, 2008).  Similarly, the role of matrix 
properties in gene delivery may be mediated by cell type, but this has not yet been systematically 
examined to date. 
 
3.2 Objective and scope 
In this study, we hypothesized that the stiffness of a cell adhesion matrix regulates non-
viral gene delivery to various extents for different cell types due to changes in gene uptake and 
intracellular processes affecting gene expression.  We examined this hypothesis by evaluating 
the delivery of plasmid DNA (pDNA) to NIH3T3 fibroblasts, D1 bone marrow stromal cells, and 
C2C12 myoblasts cultured independently on fibronectin-conjugated poly(ethylene glycol) 
hydrogels tuned to present various elastic moduli.  These three cell types can be found in skeletal 
muscle tissue, which is a common administration site for genes in preclinical and clinical 
settings.  The elastic moduli of the hydrogels were varied from 10 to 670 kPa, which 
encompasses the stiffness of skeletal muscle and collagenous bone (Engler et al, 2006).  pDNA 
encoding bone morphogenetic protein (BMP)-2, which has been used in tissue regeneration 
therapies (Lieberman et al, 1999; Kirker-Head 2000), was used as a model gene.  The uptake of 
pDNA and resulting BMP-2 expression were quantified to examine the effects of matrix stiffness 
and cell type on gene transfection efficiency.  In parallel, cell proliferation, projected cell area, 
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and nuclear aspect ratio were examined to elucidate the underlying mechanism by which matrix 
stiffness influences non-viral gene delivery for the three cell types in this study. 
 
3.3 Materials and methods 
3.3.1 Poly(ethylene glycol) diacrylate hydrogel preparation 
 Poly(ethylene glycol) (MW = 508 g/mol) diacrylate (PEGDA; Polysciences, Inc., 
Warrington, PA) hydrogels were prepared by cross-linking PEGDA molecules dissolved in 
deionized water.  The polymer concentration of the pre-gel solution was varied from 5 to 20% 
(v/v) to control hydrogel stiffness.  The pre-gel solution was mixed with ammonium persulfate 
(Sigma Aldrich, St. Louis, MO) and N,N,N’,N’-tetramethylethylenediamine (TEMED, Sigma 
Aldrich).  The concentrations of ammonium persulfate and TEMED in each sample were kept 
constant at 0.25% (w/v) and 2.5% (v/v), respectively.  The pre-gel solution was allowed to gel 
for ten minutes in 48-well tissue culture plates or between glass plates with a 1 mm spacer.  
The resulting hydrogel surface was further modified by chemically linking fibronectin to the 
surface with the use of sulfosuccinimidyl 6-(4'-azido-2'-nitrophenylamino) hexanoate (Sulfo-
SANPAH, Thermo Fisher Scientific, Rockford, IL).  The surface of the gel was covered with a 
solution of 5 mM sulfo-SANPAH in 50 mM HEPES (Fisher Scientific, Pittsburgh, PA) and 
exposed to ultraviolet light using a CHIPhERASER Model 20 (Jelight Company Inc) for 10 
minutes.  This exposure was then repeated with fresh Sulfo-SANPAH solution.  The gels were 
washed in 50 mM HEPES to remove any unbound Sulfo-SANPAH and incubated with 50 µg/ml 
fibronectin (Sigma Aldrich) overnight at 4 °C to allow the fibronectin to react with the Sulfo-
SANPAH bound to the hydrogel surface.  The gels were washed and incubated in Dulbecco’s 
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modified Eagle’s medium for three days (DMEM; Invitrogen, Carlsbad, CA) to remove any 
excess soluble chemicals. 
The compressive elastic moduli of PEGDA hydrogels were measured using a mechanical 
tester (Insight, MTS Systems, Eden Prairie, MN).  PEGDA hydrogels were prepared as described 
above between glass plates with a 1 mm spacer.  PEGDA hydrogel disks were punched and 
incubated in deionized water for one hour.  These disks were then compressed at a rate of 1 
mm/min, and the elastic moduli of the disks were calculated from the linear slope of the stress 
versus strain curve for the first 10% strain.  The swelling ratio of the hydrogels was quantified 
from the mass ratio of hydrated disks to dried disks. 
 
3.3.2 Cell culture on hydrogels of varied stiffness 
 NIH3T3 fibroblasts (ATCC, Manassas, VA), D1 bone marrow stromal cells (ATCC), and 
C2C12 myoblasts (ATCC) were cultured in Dulbecco’s modified Eagle’s medium (DMEM; 
Invitrogen, Carlsbad, CA) supplemented with 10% fetal bovine serum (FBS; Invitrogen) and 100 
units/mL penicillin-streptomycin (Invitrogen) at 37°C in a 5% CO2 incubator.  For gene delivery 
experiments, cells were seeded on hydrogel substrates at a density of 300 cells/mm
2
. 
 
3.3.3 Analysis of cell proliferation 
Cell proliferation on the hydrogel substrates was examined by quantifying the increase in 
cellular metabolic activity over four days.  Cells cultured on PEGDA hydrogels were treated 
with MTS tetrazolium (Promega, Madison, WI) one and four days after seeding.  Cellular 
metabolic activity was evaluated by the formation of a soluble formazan product, detectable with 
absorbance at 490 nm.  The absorbance values, which are linearly proportional to the number of 
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viable cells, were measured using a Synergy HT plate reader (BioTek, Winooski, VT).  The 
background absorbance for the assay was subtracted from the absorbance readings for each 
sample.  To evaluate cell proliferation over the four day culture period, absorbance values 
measured on Day 4 were normalized to those measured on Day 1. 
 
3.3.4 Delivery of pDNA encoding BMP-2 and evaluation of BMP-2 expression 
pDNA encoding BMP-2 was first obtained from Chistopher Evans at Brigham and 
Women’s Hospital (Harvard University) and expanded by Aldevron (Fargo, ND).  The pDNA 
was condensed with linear poly(ethylene imine) (MW = 25,000 g/mol) (PEI; Polysciences, Inc.).  
In brief, pDNA and PEI solutions were made in phosphate buffered saline (PBS, Invitrogen) and 
mixed at an N/P ratio of 9.  The N/P ratio represents the molar ratio between the amine groups on 
PEI and the phosphate groups on pDNA.  The resulting polyplex solution contained 50 µg/ml 
pDNA. 
Cells were seeded on fibronectin-conjugated PEGDA hydrogels in complete growth 
media.  24 hours after seeding, 50 µl of polyplex solution was administered to the cells in 500 µl 
complete growth media.  Cells remained exposed to the polyplex solution for 3 days without 
media changes after which the cell culture media was collected and BMP-2 expression was 
evaluated using a BMP-2 enzyme-linked immunosorbant assay (ELISA, R&D Systems, 
Minneapolis, MN).  In brief, the media was incubated on a microplate coated with a monoclonal 
antibody specific for BMP-2.  Any BMP-2 present in the media bound to the immobilized 
antibody and was detected with an enzyme-linked monoclonal antibody specific for BMP-2.  
Upon addition of a substrate solution, the absorbance of the final solution at 450 nm and 540 nm 
were measured using a Synergy HT plate reader.  The absorbance at 540 nm was subtracted from 
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the absorbance at 450 nm, and the amount of BMP-2 detected was calculated from a calibration 
curve established using BMP-2 standards.   The detected amount of BMP-2, measured in ng, was 
then normalized to cellular metabolic activity, which was measured with an MTS assay. 
 For certain experiments, cells were transfected with pDNA encoding BMP-2 via 
electroporation with the Neon Transfection System (Invitrogen).  With the Neon Transfection 
System 10 µl Kit, cells were suspended in Buffer R at a density of 5 × 10
6
 cells/ml.  pDNA 
encoding BMP-2 was added to the cell suspension at 50 µg/ml, and 10 µl of the resulting 
solution was aspirated into each Neon Transfection Tip.  The electroporation conditions were as 
follows:  2 pulses of 1400 V for 20 ms for fibroblasts, 3 pulses of 1600 V for 10 ms for BMSCs, 
and 3 pulses of 1650 V for 10 ms for myoblasts.  After electroporation, the contents of the tip 
were ejected into complete growth media without antibiotics, as directed by the manufacturer of 
the electroporation unit due to negative effects of antibiotics on the viability of electroporated 
cells, and plated on hydrogels with varied elastic moduli, following the same procedure as 
described above.  After 3 days, BMP-2 expression was evaluated with an BMP-2 immunoassay 
and normalized to cellular metabolic activity, as described above. 
 
3.3.5 Analysis of cellular uptake of fluorescently-labeled pDNA 
 For experiments to quantify the cellular uptake of pDNA, pDNA encoding BMP-2 was 
labeled with YOYO-1 (Invitrogen).  In brief, 200 µg of pDNA were incubated with 0.5 µl of a 1 
mM solution of YOYO-1 for 1 hour at room temperature.  For experiments to image pDNA 
uptake, pDNA encoding BMP-2 was labeled with ChromaTide Alexa Fluor 488-5-dUTP 
(Invitrogen) following the Nick Translation protocol from Invitrogen.  In brief, pDNA and 
ChromaTide Alexa Fluor 488-5-dUTP were incubated for two hours at 15 °C in a buffer 
58 
 
containing Tris-HCl (Sigma Aldrich), magnesium chloride (Sigma Aldrich), and nuclease-free 
BSA (Sigma Aldrich) along with DTT (Gold Biotechnology, St. Louis, MO), a mixture of dGTP, 
dATP, dCTP, and dTTP (Invitrogen), DNase I (Sigma Aldrich), and DNA polymerase I 
(Invitrogen).  The resulting labeled pDNA was purified with a QIAquick PCR Purification Kit 
(QIAGEN, Valencia, CA), and the concentration of pDNA in the purified solution was 
quantified with 4',6-diamidino-2-phenylindole (DAPI, Invitrogen). 
To examine the uptake of fluorescently-labeled pDNA, polyplexes were prepared by 
mixing fluorescent pDNA with linear PEI solution, as described above.  Cells were cultured on 
fibronectin-conjugated PEGDA hydrogels and exposed to polyplexes for 24 hours.  The cells 
were then washed, fixed in a formaldehyde solution, and imaged using a Leica DMI 400B 
microscope.  The fluorescent intensity of the images was quantified with integrated density using 
ImageJ software (National Institutes of Health) and normalized to cell number.  For higher 
magnification images, cells were imaged using a Zeiss LSM 700 confocal microscope. 
 
3.3.6 Analysis of projected cell area and nuclear aspect ratio 
 The projected area and nuclear aspect ratio of cells cultured on hydrogels of varied 
stiffness were analyzed from microscopy images.  Cells were cultured on fibronectin-conjugated 
PEGDA hydrogels of varied stiffness for 24 hours and fixed in a formaldehyde solution for 
staining and imaging.  The cell nuclei were stained with 4',6-diamidino-2-phenylindole (DAPI, 
Invitrogen), and the cell membranes were stained with CellMask Deep Red Plasma Membrane 
Stain (Invitrogen).  The stained cells were then imaged using a Zeiss LSM 700 confocal 
microscope.  The projected cell area was measured using ImageJ software.  The nuclear aspect 
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ratio was calculated from the lengths of the major and minor axes of nuclei as measured using 
ImageJ software: 
 
nucleus of axis minor of length
nucleus of axis major of length
ratio aspect nuclear      
Twenty cells were randomly selected from each condition for quantified analysis of projected 
area and nuclear aspect ratio.  
 
3.3.7 Statistical analysis 
 Statistical significance between two data populations was evaluated using an unpaired, 
two-tailed Student’s t-test in Microsoft Excel.  Differences were considered statistically 
significant for p < 0.05 and statistically similar for p > 0.1. 
 
3.4 Results 
3.4.1 Characterization of poly(ethylene glycol) diacrylate hydrogels 
 PEGDA hydrogels of tunable stiffness were prepared by cross-linking solutions with 
varying PEGDA concentrations.  As the PEGDA concentrations in the pre-gel solutions were 
increased from 5 to 20%, the elastic moduli of the resulting hydrogels (Egel) increased from 10 to 
670 kPa while the swelling ratios decreased from 16 to 4.5 (Figure 3.1).  The hydrogels exhibited 
minimal changes in elastic moduli and swelling ratios during seven days of incubation in cell 
culture media.  Fibronectin was chemically conjugated to the hydrogel surface using a bi-
functional linker, Sulfo-SANPAH, which has been previously reported to yield consistent protein 
conjugations independent of changes in hydrogel elastic modulus (Khatiwala et al, 2006). 
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3.4.2 Cellular uptake of pDNA encoding BMP-2 and resulting BMP-2 expression as mediated 
by matrix stiffness 
 Cellular uptake of pDNA encoding BMP-2 and subsequent BMP-2 expression were 
evaluated for fibroblasts, bone marrow stromal cells (BMSCs), and myoblasts cultured on 
fibronectin-conjugated poly(ethylene glycol diacrylate) (PEGDA) hydrogels with varied elastic 
moduli.  Polyplexes prepared by condensing fluorescently labeled pDNA with linear PEI were 
delivered to fibroblasts (Figure 3.2a-c), BMSCs (Figure 3.2d-f), and myoblasts (Figure 3.2g-i) 
cultured on hydrogels with varying Egel.  The cellular uptake of fluorescently-labeled polyplexes, 
as quantified with integrated density, was found to increase with increasing Egel for all three cell 
types.  The increase in cellular uptake of pDNA was most significant for fibroblasts while the 
cellular uptake of pDNA for myoblasts exhibited minimal dependency on substrate stiffness 
(Figure 3.3).  No fluorescence was observed from cells treated with unlabeled pDNA. 
 Next, exogenous BMP-2 expression was evaluated by measuring the amount of BMP-2 
secreted in the cell culture media.  The total amount of BMP-2 expressed, measured in 
picograms, increased with increasing Egel for all three cell types, and expression levels from 
fibroblasts were highest on all Egel when compared with expression levels from BMSCs and 
myoblasts (Figure 3.4).  Cells remained viable after polyplex delivery, as evaluated with an MTS 
assay to measure cellular metabolic activity (Figure 3.5).  When normalized to cellular metabolic 
activity, BMP-2 expression was found to increase linearly with increasing Egel for all three cell 
types, and the linear dependency of BMP-2 expression on Egel was largest for fibroblasts, as 
compared with BMSCs and myoblasts (Figure 3.6).  Untreated cells expressed no BMP-2, and 
all transfected cells expressed significant levels of BMP-2 relative to untreated controls. 
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 In parallel, cells were transfected with pDNA encoding BMP-2 via electroporation prior 
to culture on hydrogels with varied elastic moduli in order to evaluate the effects of Egel on 
exogenous gene expression independent from the effects of Egel on cellular uptake of pDNA.  
BMP-2 expression from electroporated fibroblasts increased with increasing Egel, similar to 
fibroblasts transfected with polyplexes in situ.  BMP-2 expression from electroporated BMSCs 
and myoblasts, on the other hand, were independent of Egel (Figure 3.7). 
  
3.4.3 Effect of matrix stiffness on cell proliferation 
 The effects of Egel on cell proliferation were evaluated fibroblasts, BMSCs, and 
myoblasts using an MTS assay.  Absorbance values measured on Day 4 were normalized to 
those measured on Day 1, and normalized absorbance was found to increase with increasing Egel 
for all three cell types.  The normalized absorbance on 10 kPa gels was significantly lower than 
that on 320 and 670 kPa gels for all three cell types (Figure 3.8). 
 
 
3.4.4 Effect of matrix stiffness on cellular morphology 
 The effects of Egel on projected cell area and nuclear aspect ratio were evaluated for 
fibroblasts (Figure 3.9a-c), BMSCs (Figure 3.9d-f), and myoblasts (Figure 3.9g-i) to evaluate 
whether these characteristics were related to exogenous BMP-2 expression.  For fibroblasts, the 
projected area increased with increasing Egel and was 1.5 times greater on an Egel of 670 kPa 
compared to an Egel of 10 kPa.  In contrast, the projected area for BMSCs and myoblasts were 
statistically similar on all Egel (Figure 3.10).   
In parallel, the nuclear aspect ratios of cells cultured on hydrogels with varied elastic 
moduli were calculated from the measured lengths of the major and minor axes of the nuclei.  A 
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nuclear aspect ratio equal to 1 indicates a perfectly circular nucleus, and larger nuclear aspect 
ratios indicate more elongated nuclei.  The nuclear aspect ratios for fibroblasts were significantly 
greater on an Egel of 670 kPa than an Egel of 320 kPa or 10 kPa, which indicates more elongated 
nuclei on the stiffest hydrogel.  In contrast, the nuclear aspect ratios for BMSCs and myoblasts 
were independent of Egel (Figure 3.11). 
 
3.5 Discussion 
 This study uses a cell-adherent PEGDA hydrogel to evaluate the effects of substrate 
stiffness on non-viral gene delivery for fibroblasts, BMSCs, and myoblasts.  pDNA encoding 
BMP-2 was delivered to cells cultured on fibronectin-conjugated PEGDA hydrogels of varying 
stiffness.  When cells were transfected in situ via polyplex delivery, the cellular uptake and 
subsequent BMP-2 expression for fibroblasts were most dependent on substrate stiffness when 
compared with BMSCs and myoblasts.  When cells were transfected prior to culture via 
electroporation, BMP-2 expression from fibroblasts was dependent on substrate stiffness while 
BMP-2 expression from BMSCs and myoblasts were independent of substrate stiffness.  To 
understand the relationship between substrate stiffness and non-viral gene delivery, the effects of 
substrate stiffness on cell proliferation, projected cell area, and nuclear aspect ratio were 
evaluated for all three cell types.  Fibroblasts, BMSCs, and myoblasts all exhibited an increase in 
cell proliferation with increasing substrate stiffness while only fibroblasts demonstrated an 
increase in projected cell area and nuclear elongation with increasing substrate stiffness. 
 The results from this study indicate that the effects of substrate stiffness on pDNA 
delivery may be related to both the cellular uptake of pDNA as well as intracellular processes 
which affect gene expression.  The extent to which substrate stiffness influenced BMP-2 
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expression varied among cell types, likely related to differences in cellular sensitivity to 
mechanical signals from the matrix.  With polyplex delivery, fibroblasts exhibited the most 
pronounced increase in cellular uptake of pDNA with increasing substrate stiffness when 
compared with BMSCs and myoblasts, resulting in the most significant increase of BMP-2 
expression.  BMP-2 expression from BMSCs and myoblasts were less dependent on substrate 
stiffness compared with fibroblasts, likely related to decreased effects of substrate stiffness on 
cellular uptake of pDNA.  Fibroblasts electroporated with pDNA encoding BMP-2 prior to 
culture on the hydrogel substrates exhibited an increase in BMP-2 expression with increasing 
substrate stiffness, suggesting that matrix stiffness may also influence intracellular processes for 
BMP-2 production since electroporation should normalize any effects of substrate stiffness on 
cellular uptake of pDNA.  In contrast, BMP-2 expression from BMSCs and myoblasts 
electroporated with pDNA were not dependent on substrate stiffness, implying that effects of 
substrate stiffness on non-viral gene delivery for BMSCs and myoblasts were related mostly to 
cellular uptake of pDNA. 
 Previous studies have indicated that the influence of matrix stiffness on non-viral gene 
delivery may be primarily due to increased frequency of cell cycle on substrates of increasing 
stiffness allowing cells to uptake more pDNA (Kong et al, 2005).  In this study, however, the 
effects of substrate stiffness on cellular uptake of pDNA could not be explained solely with 
changes in cell proliferation.  The increase in proliferation of fibroblasts and BMSCs on 
substrates of increasing stiffness corresponded with increased cellular uptake of pDNA, but to 
varied extents.  Myoblasts, on the other hand, exhibited no significant increase in cellular uptake 
of pDNA with increasing substrate stiffness despite an increase in proliferation.  Results from 
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this study suggest that the effects of cellular proliferation rate on cellular uptake of pDNA may 
not be universal for all cell types.   
We suggest that substrate stiffness modulates cellular uptake of pDNA by affecting the 
extent of cell spreading in addition to cellular proliferation rate.  The extent of cell spreading has 
been reported to influence endocytic activities (Adler and Leong, 2010); thus, we suggest that the 
increased projected area of fibroblasts on stiffer substrates increased endocytosis, resulting in an 
increased uptake of pDNA.  The limited effects of substrate stiffness on the projected cell area of 
BMSCs and myoblasts, on the other hand, limited the effects of substrate stiffness on cellular 
uptake of pDNA.  In addition, we propose that intracellular processes for gene expression are 
related to changes in nuclear morphology, as increasing substrate stiffness resulted in significant 
nuclear elongation for fibroblasts but had minimal effects on nuclear shape for BMSCs and 
myoblasts.  Previous studies have reported that nuclear shape can modulate endogenous gene 
expression and protein production, possibly due to changes in chromatin structure, though the 
exact mechanism is unclear (Thomas et al, 2002; Dahl et al, 2008).  Similarly, nuclear 
morphology may be related to exogenous gene expression for fibroblasts in this study, but 
systematic future studies are needed for better understanding. 
This study examined three different cell lines, and it is necessary to examine the role of 
matrix stiffness on primary cells in future studies.  Future work is also needed to extend this 
study to three-dimensional microenvironments, which more closely mimic conditions found in 
vivo.  Previous studies have indicated that gene delivery to cells cultured in three-dimensions is 
dependent on the pore size within hydrogel matrices (Shepard et al, 2010) as well as matrix 
stiffness (Gojgini et al, 2011). 
65 
 
Overall, we propose that the results from this study provide important guidelines for 
developing and improving gene delivery strategies.  Therapeutic genes enter a complex 
microenvironment when administered to the body, and ECM properties, such as stiffness, are 
known to change with tissue type as well as the age and health conditions of patients (Kong and 
Mooney, 2007).  It is thus valuable to establish a better understanding of the effects of matrix 
properties on gene delivery.  Furthermore, the results from this study will be useful for designing 
implantable provisional matrices for various gene-based therapies, including tissue regeneration 
(Shea et al, 1999; Bonadio et al, 1999; Geiger et al, 2005; Huang et al, 2005; Dang and Leong, 
2006). 
 
3.6 Conclusion 
 In conclusion, this study demonstrates that the stiffness of a cell-adherent matrix plays an 
important role in non-viral gene delivery and that the effects of matrix stiffness are mediated by 
cell type.  Exogenous gene expression from fibroblasts, when compared with that from BMSCs 
and myoblasts, exhibited the greatest dependency on substrate stiffness.  The more pronounced 
influence of matrix stiffness on non-viral gene delivery for fibroblasts was attributed to a higher 
sensitivity to changes in matrix stiffness for fibroblasts, as demonstrated by more significant 
changes in cell area and nuclear aspect ratio, when compared with BMSCs and myoblasts.  
Ultimately, the results of this study are useful for developing advanced gene delivery strategies 
and assembling provisional matrices for gene-based therapies.  
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3.8 Figures 
 
Figure 3.1  PEGDA Hydrogel characterization.  Elastic moduli (■) and swelling ratios (▲) of PEGDA hydrogels 
controlled by PEGDA concentration.  As the PEGDA concentration was increased from 5 to 20%, the elastic 
modulus increased from 10 to 670 kPa while the swelling ratio decreased from 16 to 4.5.  
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Figure 3.2  Uptake of fluorescently-labeled pDNA.  Fluorescent images of cellular uptake of pDNA for NIH3T3 
fibroblasts (a-c), D1 BMSCs (d-f), and C2C12 myoblasts (g-i) cultured on 10, 320, and 670 kPa hydrogels.  
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Figure 3.3  Quantification of cellular uptake of pDNA.  The cellular uptake of fluorescently-labeled pDNA to 
fibroblasts (■), BMSCs (●), and myoblasts (▲) as evaluated with integrated density from fluorescent images.  
Cellular uptake of pDNA on 10 kPa gels was statistically different from that on 320 and 670 kPa gels for fibroblasts 
and BMSCs (*p < 0.05).  Values and error bars represent the mean and standard deviation characterized from four 
independent images, each containing at least ten cells. 
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Figure 3.4  Effects of substrate stiffness on absolute BMP-2 expression.  BMP-2 expression in picograms 
resulting from in situ delivery of polyplexes containing pDNA encoding BMP-2 to NIH3T3 fibroblasts, D1 BMSCs, 
and C2C12 myoblasts cultured on fibronectin-conjugated PEGDA hydrogels with elastic moduli of 10, 320, and 670 
kPa.  Differences between BMP-2 expression levels on the stiffest (670 kPa) and softest (10 kPa) gels were 
statistically significant for all cell types (*p < 0.05).  Values and error bars represent the mean and standard 
deviation characterized from four independent samples. 
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Figure 3.5  Effects of substrate stiffness on cellular metabolic activity.  Cellular metabolic activity, as evaluated 
with an MTS assay, for NIH3T3 fibroblasts, D1 BMSCs, and C2C12 myoblasts cultured on fibronectin-conjugated 
PEGDA hydrogels with elastic moduli of 10, 320, and 670 kPa.  Values and error bars represent the mean and 
standard deviation characterized from four independent samples. 
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Figure 3.6  Effects of substrate stiffness on normalized BMP-2 expression.  BMP-2 expression, measured in 
nanograms, was normalized to cellular metabolic activity, as evaluated with absorbance from an MTS assay for 
fibroblasts (■), BMSCs (●), and myoblasts (▲).  Differences between normalized BMP-2 expression on the stiffest 
(670 kPa) and softest (10 kPa) gels were statistically significant for all cell types (*p < 0.05).  Values and error bars 
represent the mean and standard deviation characterized from four independent samples from each experiment. 
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Figure 3.7  Effects of substrate stiffness on BMP-2 expression from electroporation.  BMP-2 expression from 
NIH3T3 fibroblasts (■), D1 BMSCs (●), and C2C12 myoblasts (▲) electroporated with pDNA encoding BMP-2 
prior to culture on fibronectin-conjugated PEGDA hydrogels with elastic moduli of 10, 320, and 670 kPa.  BMP-2 
expression, measured in nanograms, was normalized to cellular metabolic activity, as evaluated with absorbance 
from an MTS assay.  Differences between BMP-2 expression on the stiffest (670 kPa) and softest (10 kPa) gels were 
statistically significant for fibroblasts (*p<0.05).  BMP-2 expression on the stiffest (670 kPa) and softest (10 kPa) 
gels were statistically similar for BMSCs and myoblasts (**p>0.1).  Values and error bars represent the mean and 
standard deviation characterized with from four independent samples. 
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Figure 3.8  Effects of substrate stiffness on cell proliferation.  Proliferation of NIH3T3 fibroblasts (■), D1 
BMSCs (●), and C2C12 myoblasts (▲), as evaluated with normalized absorbance values from an MTS assay after 
four days of culture on fibronectin-conjugated PEGDA hydrogels with elastic moduli of 10, 320, and 670 kPa.  For 
each cell type and elastic modulus, absorbance values measured on Day 4 were normalized to those measured on 
Day 1.  Normalized absorbance on 10 kPa gels were statistically different from that on 320 and 670 kPa gels for all 
three cell types (*p < 0.05). Values and error bars represent the mean and standard deviation characterized from four 
independent samples.   
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Figure 3.9  Analysis of cellular morphology.  Fluorescent images of NIH3T3 fibroblasts (a-c), D1 BMSCs (d-f), 
and C2C12 myoblasts (g-i) cultured on fibronectin-conjugated PEGDA hydrogels with elastic moduli of 10, 320, 
and 670 kPa.  The cell membranes (red) and nuclei (blue) were stained with a CellMask Deep Red Plasma 
Membrane Stain and DAPI, respectively.  
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Figure 3.10  Effects of substrate stiffness on projected cell area.  Projected cell area for NIH3T3 fibroblasts (■), 
D1 BMSCs (●), and myoblasts (▲) cultured on fibronectin-conjugated PEGDA hydrogels with elastic moduli of 10, 
320, and 670 kPa.  Differences between projected cell area on the stiffest (670 kPa) and softest gels (10 kPa) were 
statistically significant for fibroblasts (*p < 0.05).  Projected cell area on the stiffest (670 kPa) and softest (10 kPa) 
gels were statistically similar for BMSCs and myoblasts (**p > 0.1).  Values and error bars represent the mean and 
standard deviation characterized from twenty independent, randomly-selected cells. 
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Figure 3.11  Effects of substrate stiffness on nuclear aspect ratio.  Nuclear aspect ratio for NIH3T3 fibroblasts 
(■), D1 BMSCs (●), and C2C12 myoblasts (▲) cultured on fibronectin-conjugated PEGDA hydrogels with elastic 
moduli of 10, 320, and 670 kPa.  Differences between nuclear aspect ratios on the stiffest (670 kPa) and softest (10 
kPa) gels were statistically significant for fibroblasts (*p < 0.05).  Nuclear aspect ratios on the stiffest (670 kPa) and 
softest (10 kPa) gels were statistically similar for BMSCs and myoblasts (**p > 0.1).  Values and error bars 
represent the mean and standard deviation characterized from twenty independent, randomly-selected cells. 
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CHAPTER 4:  MICROVASCULAR STAMP WITH GENETICALLY MODIFIED 
CELLS FOR REVASCULARIZATION THERAPIES 
 
 
4.1 Introduction 
Revascularization therapies have the potential to treat a wide array of diseases, including 
ischemic disease and cardiovascular disease, which is the leading cause of death in the United 
States (Lei et al, 2005; Heron et al, 2009).  Revascularization is also critical for wound healing 
and tissue regeneration.  Tissues thicker than 100 µm must be vascularized for the transport of 
oxygen and nutrients due to diffusion limitations (Khademhoseini et al, 2009).  This has thus far 
been a limiting factor in repairing and regenerating thick or complex tissues (Levenberg et al, 
2005; Rouwkema et al, 2008).  In efforts to restore blood flow to ischemic tissues or to 
vascularize engineered tissues, angiogenic proteins or genes can be administered to stimulate 
angiogenesis, which refers to the formation of new blood vessels from existing vasculature (Lei 
et al, 2004). 
Vascular endothelial growth factor (VEGF) has been widely investigated for use in 
revascularization therapies and has been shown to support angiogenesis both in vitro and in vivo 
(Ferrara et al, 2003).  Specifically, delivery of non-viral genes encoding VEGF has been 
increasingly studied to stimulate angiogenic activities in a more sustained manner than direct 
protein delivery.  In order to further improve the efficacy of genes encoding VEGF, plasmid 
DNA encoding VEGF are frequently encapsulated in biomaterial scaffolds for implantation 
(Zisch et al, 2003; Kong et al, 2008).  Alternatively, cells genetically manipulated to express 
VEGF ex vivo can be transplanted to stimulate angiogenesis, and such use of genetically 
modified cells may be advantageous in facilitating localized expression for angiogenic therapies.  
However, this approach is still limited by difficulties in regulating the level of cellular exogenous 
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expression of VEGF (Lei et al, 2004).  The dose of VEGF is critical for therapeutic applications, 
as high doses of VEGF result in abnormal angiogenesis (Ozawa et al, 2004; Ehrbar, 2004). 
For successful revascularization therapies, it is critical to control the number, size, 
spacing, and maturity of neovessels at the target site (Dor et al, 2003; Chen et al, 2007); 
however, technologies to do so are still lacking.  Previous studies have demonstrated that blood 
vessel formation can be regulated by controlling the spatio-temporal delivery of angiogenic 
factors (Silva et al, 2010).  For example, a bilayer scaffold synthesized to control the temporal 
delivery of VEGF was shown to regulate the density, size, and maturity of newly formed blood 
vessels (Chen et al, 2007).  While such studies provide crucial insight to regulating the formation 
of new blood vessels, precise patterning of functional blood vessels at physiologically relevant 
length-scales remains a challenge.  Various microfabrication techniques have been used to 
pattern molecules or cells for tissue engineering applications and biological studies 
(Khademhosseini et al, 2006), but such techniques are still unable to direct blood vessel 
formation. 
Recently, researchers in the Kong Lab developed a “living” microvascular stamp that was 
able to release multiple angiogenic factors to support neovessel formation along microchannels 
in the stamp.  The stamp incorporated cells that secrete angiogenic factors in a three-dimensional 
hydrogel matrix to promote cellular expression of angiogenic factors.  Upon implantation in an 
in vivo angiogenesis model, the stamp promoted the desired pattern of neovessels based on its 3D 
geometry and allowed for controlled spacing and density of neovessel formation (Jeong et al, 
2011; Figure 4.1).  It is proposed that the efficacy of this vascular stamp be further improved 
with a more refined control of angiogenic growth factor expression from the encapsulated cells.  
Therefore, it would be valuable to incorporate cells transfected with plasmid DNA (pDNA) 
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encoding VEGF into the microvascular stamp to potentially control VEGF expression with 
pDNA dose, cell density, and matrix properties. 
 
4.2 Objective and scope 
We hypothesize that the microvascular stamp containing cells transfected with pDNA 
encoding VEGF will release VEGF along pre-defined microchannel patterns and promote 
formation of micro-sized blood vessels according to the microchannels engraved into the stamp.  
Furthermore, the viability of transfected cells and exogenous production of VEGF in the stamp 
will be tuned with the dosage of pDNA encoding VEGF and permeability of the hydrogel.  To 
examine this hypothesis, NIH3T3 fibroblasts were first transfected with varying amounts of 
pDNA encoding VEGF165 to evaluate cell viability and VEGF production.  Then, the cells 
transfected with the proper dose of pDNA were used to assemble a microvascular stamp (Jeong 
et al, 2011).  These cells were encapsulated in a hydrogel system consisting of poly(ethylene 
glycol) diacrylate (PEGDA) of different molecular weights or a mixture of PEGDA and 
methacrylic alginate (MA) using a stereolithography apparatus (SLA).  The hydrogel 
permeability and subsequent cell viability were controlled with the molecular weight of PEGDA 
and the addition of MA.  The SLA unit was used to fabricate microchannels within the hydrogel 
structure to direct blood vessel growth.  The resulting microvascular stamp was implanted on a 
chick chorioallantoic membrane (CAM) to assess neovessel formation in vivo. 
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4.3 Materials and methods 
4.3.1 Methacrylic alginate synthesis 
The alginate used in this study (molecular weight ~ 50,000 g/mol) was obtained by 
irradiating alginate rich in gluronic acid resides (LF20/40, FMC Biopolymer, Philadelphia, PA) 
with a cobalt-60 source for 4 hours at a dose of 5.0 Mrad (Kong et al, 2002).  2-
aminoethylmethacrylate (Sigma Aldrich, St. Louis, MO) was conjugated to alginate using 
carbodiimide chemistry (Figure 4.2).  In brief, alginate was dissolved in 0.1 M 2-(N-morpholino) 
ethanesulfonic acid (MES, Sigma Aldrich) buffer at a concentration of 1% (w/v).  
Hydroxybenzotriazole (HOBt, Sigma), 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC, 
Thermo Scientific, Rockford, IL), and 2-aminoethylmethacrylate were added to the alginate 
solution and stirred.  The molar ratios of HOBt to 2-aminoethylmethacrylate and EDC to 2-
aminoethylmethacrylate were both kept constant at 2:1.  After the mixture was allowed to react 
for 18 hours, the solution was dialyzed extensively against deionized water for three days while 
changing the deionized water every 12 hours.  Finally, the dialyzed solution was lyophilized and 
reconstituted to a 3 wt % stock solution.  For this study, the number of acrylate groups 
conjugated to each alginate chain was kept constant at 60 as confirmed by 1H-NMR (300 MHz, 
QE-300, General Electric), as previously reported (Cha et al, 2009). 
 
4.3.2 Poly(ethylene glycol) diacrylate synthesis 
Poly(ethylene glycol) diacrylate (PEGDA) was synthesized from poly(ethylene glycol) 
(PEG, molecular weight ~ 1000 g/mol, Sigma Aldrich) and acryloyl chloride (Sigma Aldrich).  
PEG was first dissolved in dichloromethane at a concentration of 10 wt %.  Acryloyl chloride 
and triethylamine (Fisher Chemical, Fairlawn, NJ) were added to the PEG solution and stirred 
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under dry N2 gas  (Figure 4.3).  PEG, acryloyl chloride, and triethylamine were added at a ratio 
of 1:4:4.  After the mixture was allowed to react overnight, the insoluble triethylamine-HCl 
byproduct was removed by filtration.  The PEGDA1000 product in the remaining solution was 
then precipitated by adding ice-cold ether.  The precipitated crude product was dissolved in 
deionized water and dialyzed for one day to remove any byproducts or unreacted starting 
materials and lyophilized.  The conjugation of acrylate groups on PEG was confirmed by 1H-
NMR (300 MHz, QE-300, General Electric). 
 
4.3.3 Hydrogel formulation and analysis 
Hydrogels were prepared from methacrylic alginate, PEGDA1000 (molecular weight of 
repeat unit ~ 1000 g/mol), and PEGDA400 (molecular weight of repeat unit ~ 400 g/mol, 
Polysciences, Inc., Warrington, PA) through photopolymerization.  PEGDA400, PEGDA1000, and 
PEGDA1000-MA solutions were prepared in Dulbecco’s modified Eagle’s medium (DMEM; 
Invitrogen, Carlsbad, CA) at constant solids concentrations of 10% w/v.  PEGDA400 and 
PEGDA1000 solutions contained 10% w/v PEGDA in DMEM.  PEGDA1000-MA solutions 
contained 8.5% w/v PEGDA and 1.5% w/v MA in DMEM.  A 10% w/v solution of the 
photointiator, Irgacure 2959 (Ciba, Tarryton, NY), was prepared in dimethyl sulfoxide (DMSO, 
Fisher Chemical), and 10 µl of the resulting stock solution was added to 1 ml of the pregel 
solution.  The mixture was then poured between glass plates with a 1mm spacer and exposed to 
ultraviolet light using a CHIPhERASER Model 20 (Jelight Company Inc, Irvine, CA) for 10 
minutes.  Hydrogel disks were punched using a 5 mm puncher and incubated in phosphate 
buffered saline (PBS, Invitrogen). 
The swelling ratio of the hydrogels was quantified with the mass ratio of hydrated disks 
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to dried disks.  The average pore size (ζ) within PEGDA cross-linked networks was calculated 
from Eq 1 (Raeber et al, 2005): 
  (    
    
)(  ̅
 )
   
 Eq 1 
where      represents the polymer volume fraction gel in the swollen state, which is equal to the 
inverse of the swelling ratio, and (  ̅
 )
   
 represents the unperturbed mean-square end-to-end 
distance of the molecule.  For alginate, this value is 254 nm.  For PEG, (  ̅
 )
   
 was calculated 
from Eq 2: 
 (  ̅
 )
   
      Eq 2 
Where n represents the number of repeat units, l represents the average monomer length (1.46 
Å), and Cn represent the characteristic ratio for PEG (= 4). 
 
4.3.4 Cell culture and transfection 
 NIH3T3 fibroblasts (ATCC, Manassas, VA) were cultured in DMEM supplemented with 
10% fetal bovine serum (FBS; Invitrogen) and 100 units/mL penicillin-streptomycin (Invitrogen) 
at 37°C in a 5% CO2 incubator.  Plasmid DNA (pDNA) encoding VEGF165 was first obtained 
from Dr. Douglas Losordo (Northwestern University) and expanded by Aldevron (Fargo, ND).  
Cells were transfected with plasmid pDNA encoding VEGF165 through electroporation with the 
Neon Transfection System (Invitrogen).  With the Neon Transfection System 100 µl Kit, cells 
were suspended in Buffer R at a density of 50 × 10
6
 cells/ml.  pDNA was added to the cell 
suspension at varying concentrations, and 100 µl of the resulting solution was aspirated into each 
Neon Transfection Tip.  Cells were electroporated with 2 pulses of 1350 V for 20 ms after which 
the contents of the tip were ejected into complete growth media without antibiotics.  For cell 
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encapsulation experiments, cells were electroporated in a solution that contained 0.1 µg/µl 
pDNA and cultured for 24 hours prior to encapsulation. 
 
4.3.5 Cell encapsulation in hydrogels 
Cells were encapsulated in 1 mm thick hydrogels prepared using a CHIPhERASER 
Model 20 as described above.  For encapsulation within this hydrogel system, cells were mixed 
with PEGDA400, PEGDA1000, and PEGDA1000-MA pregel solutions at a cell density of 1 million 
cells/ml.  The solutions were polymerized as described above.  Disks were punched and placed 
directly into complete growth media for culture in a 37°C, 5% CO2 incubator.  Cell viability was 
analyzed 4 hours and 24 hours after encapsulation with MTS tetrazolium [3-(4,5-
dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner 
salt] (Promega Corporation, Madison, WI).  In brief, cell viability was indicated by the formation 
of a soluble formazan product after treatment with the MTS reagent.  The amount of formazan 
produced was quantified with absorbance at 490nm, and the quantity of formazan measured was 
directly proportional to the number of viable cells in culture. 
 
4.3.6 Cell encapsulation in microvascular stamps using SLA 
Cells were mixed with the pre-gel solution at a density of 5 million cells/ml or 10
5
 
cells/ml.  The pre-gel solution consisted of 18.5 % w/v PEGDA and 1.5% w/v MA dissolved in 
DMEM.  The photoinitiator, Irgacure 2959, was added to the pre-gel solution at a final 
concentration of 0.2% w/v.  A stereolithography apparatus (SLA, Model 250/50, 3D Systems, 
Rock Hill, South Carolina) was used to photopolymerize the pre-gel solution to form hydrogels 
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(Figure 4.4).  The resulting hydrogels were cylindrical disks with diameters of 5 mm and 
thicknesses of 200 µm, as specified with a computer-aided design (CAD) model. 
 
4.3.7 Cell viability and VEGF secretion assays 
For in vitro experiments to evaluate the optimal pDNA concentration for electroporation, 
cells were electroporated with varying pDNA concentrations, and 5,000 cells were plated in 100 
µl complete growth media without antibiotics.  The media was changed every 24 hours and 
collected on Days 1, 2, and 4 for VEGF analysis.  Cell viability was analyzed in parallel with an 
MTS reagent, as described above.  For in vitro experiments to evaluate VEGF secretion from 
microvascular stamps, the media was collected four hours after fabrication and on Days 1, 4, and 
7 for VEGF analysis.  Cell viability was analyzed in parallel with an MTS reagent. 
The amount of VEGF present in the media collected from in vitro studies was quantified 
with a VEGF enzyme-linked immunosorbant assay (ELISA, R&D Systems, Minneapolis, MN).  
In brief, microplates were coated with mouse anti-human VEGF165.  The samples to be assayed 
were then incubated on the microplate and allowed to bind to the immobilized antibodies.  Next, 
biotinylated mouse anti-human VEGF165 was added, followed by streptavidin conjugated to 
horseradish-peroxidase.  Finally, upon addition of a substrate solution, the absorbance of the 
final solution at 450 nm and 540 nm were measured with a Synergy HT plate reader (BioTek, 
Winooski, VT).  The absorbance at 540 nm was subtracted from the absorbance at 450 nm, and 
the amount of VEGF detected was calculated from a calibration curve established using VEGF 
standards. 
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4.3.8 Chorioallontic membrane-based angiogenesis assay 
Embryonic chicken eggs (Hy-Line W-36, Poultry Research Farm, University of Illinois, 
Urbana, Illinois) were incubated at 37°C with 5% CO2.  On the ninth day of gestation, a small 
window (1 cm × 1cm) was created in each egg shell.  After an additional day of incubation to 
stabilize the embryos, hydrogel disks were implanted on each chorioallontic membrane (CAM) 
(Figure 4.5).  After 7 days of incubation with the hydrogel disks, the membranes were fixed with 
10% neutral buffered formalin (NBF) for 20 hours for further analysis.  CAM images were 
captured using a Leica S6C stereomicroscope. 
 
4.4 Results and discussion 
4.4.1 Effects of pDNA dosage on gene expression and cell viability 
NIH3T3 fibroblasts were electroporated with varying doses of plasmid DNA (pDNA) 
encoding vascular endothelial growth factor (VEGF).  The concentration of pDNA in the 
electroporation medium was varied from 0 µg/µl to 0.3 µg/µl, and the resulting cell viability and 
VEGF secretion were evaluated on Days 1, 2, and 4 after initially plating 5,000 cells.  With a 
pDNA dose of 0 µg/µl, cells did not express any detectable VEGF (data not shown).  As the 
concentration of pDNA was increased from 0.05 to 0.2 µg/µl, the VEGF expression increased 
from 2 to 46 ng after 1 day.  Further increase of pDNA dosage to 0.3 µg/µl resulted in no 
statistically significant increase in VEGF expression (Figure 4.6).  The cellular VEGF production 
decreased significantly on Day 4, regardless of the pDNA dosage.   
Relative cell viability was also evaluated by normalizing the viability of transfected cells 
to the viability of cells electroporated with 0 µg/µl pDNA.  Increasing the pDNA dosage from 
0.05 to 0.1 µg/µl, which increased VEGF expression from 1 to 40 ng on Day 2, had minimal 
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effects on cell viability.  As the concentration of pDNA was increased further from 0.1 µg/µl to 
0.2 µg/µl, minimal changes in VEGF expression were observed, and the relative cell viability 
decreased significantly (Figure 4.7).  These results demonstrate that a pDNA dosage between 
0.05 and 0.1 µg/µl would be appropriate to stimulate cellular exogenous production of VEGF 
while retaining cell viability. 
 
4.4.2 Effects of polymer composition on hydrogel pore size and viability of encapsulated cells 
Hydrogel disks of three different compositions were prepared from a solution containing 
10% w/v PEGDA400, a solution containing 10% w/v PEGDA1000, and a solution containing 8.5% 
PEGDA1000 and 1.5% MA.  The swelling ratios of the resulting hydrogel disks were quantified 
and used to calculate the average pore size within the hydrogel network using Eq 1 and Eq 2.  
For PEGDA hydrogels, increasing the molecular weight from 400 to 1000 increased the average 
pore size from 11 nm to 30 nm.  The addition of MA further increased the swelling ratio of the 
hydrogels, and the resulting pore size, as calculated from the unperturbed mean-square end-to-
end distance of both PEG and alginate, increased to 121 nm (Figure 4.8).  The viability of 
encapsulated cells increased with increasing hydrogel permeability, as characterized with pore 
size.  While cells were not viable in PEGDA400 gels, the increased permeability of PEGDA1000 
gels were able to support cell viability.  Incorporation of MA further increased cell viability, 
though the difference was not statistically significant within 24 hours of encapsulation (data not 
shown).  We envisage, however, that the difference between conditions will increase with a 
longer incubation period. 
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4.4.3 Cell viability and VEGF secretion from microvascular stamps 
 
First, NIH3T3 fibroblasts transfected with pDNA encoding VEGF were incorporated in 
hydrogel microvascular stamps using SLA at a cell density of 5 million cells/ml.  Based on 
studies conducted in Section 4.4.2, the microvascular stamp was prepared by cross-linking 
PEGDA1000 and MA.  Cells remained viable after the fabrication process, as exhibited with an 
MTT stain 24 hours following encapsulation (Figure 4.9).  The amount of VEGF secreted four 
hours after fabrication and the amount of VEGF secreted on Days 1, 4, and 7 were quantified.  
The cell viability was analyzed in parallel.  Four hours after encapsulation, no detectable VEGF 
was released from the microvascular stamp (data not shown).  After 24 hours, significant 
amounts of VEGF were released from the vascular stamp.  The amount of VEGF released from 
the vascular stamp decreased over seven days (Figure 4.10), but the 8 ng released on Day 7 is 
within the concentration needed to stimulate angiogenesis (Jeong et al, 2011).  Cell viability was 
analyzed on Days 1, 4, and 7 and normalized to cell viability 4 hours after fabrication.  A 
majority of the cells in the vascular stamp remained viable up to Day 4, but viability decreased 
by Day 7 (Figure 4.11).  However, it is noteworthy that more than 50% of the cells remained 
viable in a 3D hydrogel matrix during 7 days of encapsulation, which is difficult to achieve with 
a conventional synthetic hydrogel system. 
Overall, we suggest that the gradual decrease in cellular exogenous VEGF production 
during the first four days of culture results from intrinsic gene silencing mechanisms, such as 
cytosine methylation (Hong et al, 2001; Glover et al, 2005), and not early cell death.  The 
continued decrease of VEGF production between Days 4 and 7 may be attributed to both 
intrinsic gene silencing and cell death.  Despite the decrease in VEGF production, these results 
indicate that the microvascular stamp consisting of a permeable hydrogel with cells modified to 
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produce VEGF could release angiogenic factors at an implant site, as described in the following 
section. 
 
4.4.4 Blood vessel formation from microvascular stamps in a CAM-based angiogenesis assay 
Finally, the hydrogel-based vascular stamps were implanted on a chorioallantoic 
membrane (CAM).  The vascular stamps were assembled with a permeable PEGDA1000-MA 
hydrogel and fabricated with 500 µm-diameter microchannels.  NIH3T3 fibroblasts transfected 
with pDNA encoding VEGF were incorporated in the microvascular stamps at a density of 10
5
 
cells/ml.  When implanted on a CAM, this microvascular stamp stimulated the growth of 
neovessels along its circular patterns (Figure 4.12A).  In addition, the patterned neovessels were 
connected, suggesting that new capillaries sprouted from neighboring blood vessels.  In contrast, 
no patterned neovessels formed when the microvascular stamps were constructed with cells that 
had not been transfected with pDNA encoding VEGF (Figure 4.12B). 
Increasing the density of cells within the microvascular stamps to 5 × 10
6
 cells/ml 
resulted in a pro-inflammatory response, characterized by the formation of fibrous tissue on the 
surface of the vascular stamp (Figure 4.13).  In contrast, inflammation was not observed on 
stamps fabricated with cells that had not been transfected with pDNA encoding VEGF at the 
same cell density (data not shown).  This result demonstrates the importance of VEGF dosage, 
which was controlled by cell density in this study, in stimulating either neovessel formation or 
pro-inflammation. 
We propose that the microvascular stamp combined with a gene delivery strategy in this 
study is advantageous over the previous microvascular stamp, which was equipped with cells 
chemically stimulated to express endogenous angiogenic factors.  The expression level of 
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angiogenic factors can be more readily tuned in the microvascular stamp used in this study.  It 
would also possible to combine these VEGF-producing cells with other cells transfected with 
pDNA encoding supplemental angiogenic growth factors, such as Angiopoietin or platelet-
derived growth factor (PDGF).  Furthermore, we envisage that the VEGF expression level in the 
microvascular stamp could be further tuned with the mechanical and chemical properties of a 
hydrogel matrix, as discussed in previous chapters, as well as the permeability of the hydrogel 
matrix.  Overall, the microvascular stamp from this study could potentially be used to promote 
the formation of organized vasculatures and facilitate transport in tissue regeneration therapies or 
engineered 3D tissues. 
 
4.5 Conclusion 
Overall, this study demonstrates that a microvascular stamp equipped with cells 
genetically manipulated to produce exogenous VEGF is able to control the growth and spacing 
of blood vessels.  The dosage of pDNA encoding VEGF, the hydrogel permeability, and the cell 
density were all factors in controlling the amount of VEGF released along the microchannels to 
control neovessel formation while circumventing host inflammation.  Specifically, the pDNA 
dosage and hydrogel permeability were key factors in retaining cell viability in a 3D matrix, and 
cell density was an important factor in tuning the balance between angiogenesis and 
inflammation.  We propose that this microvascular stamp, which incorporates gene delivery 
strategies, may be useful in improving the quality of revascularization therapies. 
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4.7 Figures 
 
 
Figure 4.1  “Living” microvascular stamp for patterning of functional neovessels.  The microvascular stamp 
incorporates cells in a hydrogel structure for patterned blood vessel formation (Jeong et al, 2011). 
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Figure 4.2   Synthesis of methacrylic alginate (MA).  First, low molecular weight alginate was obtained by ϒ-
irradiation of alginate rich in gluronic acid resides. Aminoethylmethacrylate was then conjugated to the alginate 
molecules using carbodiimide chemistry. 
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Figure 4.3   Synthesis of poly(ethylene glycol) diacrylate (PEGDA).  Poly(ethylene) glycol (PEG) was reacted 
with acryloyl chloride and triethylamine to form PEGDA. 
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Figure 4.4  Stereolithography apparatus (SLA) for microvascular stamp fabrication.  Cells were suspended in 
a pre-gel solution of PEGDA and methacrylic alginate (MA).  The pre-gel solution was then polymerized using 
SLA. 
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Figure 4.5  In-shell CAM angiogenesis assay.    (A) Embryonic chicken eggs were incubated at 37 °C with 5 % 
CO2.  On the 9th day of gestation, a small window (1 × 1 cm) was created on top of each egg.  After one day of 
additional incubation to stabilize the embryos, hydrogels were implanted on top of the CAM.  Membranes were 
excised after seven days of incubation.  (B) Photo of an in-shell CAM. 
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Figure 4.6  Effect of pDNA dose on VEGF expression.  VEGF expression increased as the pDNA dose was 
increased from 0.05 µg/µl to 0.2 µg/µl but exhibited no statistically significant difference as the pDNA dose was 
increased further to 0.3 µg/µl (*p > 0.1).  Values and error bars represent the mean and standard deviation from four 
independent measurements. 
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Figure 4.7  Effect of pDNA dose on cell viability.  As the pDNA concentration was increased from 0.1 µg/µl to 0.2 
µg/µl, the relative viability, which refers to the viability of transfected cells normalized with the viability of cells 
electroporated with 0 µg/µl pDNA, decreased.  The differences between relative viability with 0.1 µg/µl and 0.2 
µg/µl were statistically significant at all time points (*p < 0.05).  Values and error bars represent the mean and 
standard deviation from four independent measurements. 
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Figure 4.8  Hydrogel pore size.  As the molecular weight of the PEGDA was increased from 400 to 1000 g/mol, 
the pore size of the hydrogel network increased.  The addition of methacrylic alginate (MA) further increased the 
pore size in the hydrogel network.  PEGDA400 and PEGDA1000 represent pure PEGDA hydrogels formed from 
PEGDA with molecular weights of 400 and 1000 g/mol, respectively.  PEGDA1000-MA represents a hydrogel 
formed from PEGDA1000 and methacrylic alginate (MA).  The total polymer concentration of all solutions was 
kept constant at 10% (w/v). Values and error bars represent the mean and standard deviation from four independent 
measurements. 
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Figure 4.9  Cell viability following encapsulation in microvascular stamp. NIH3T3 fibroblasts transfected with 
pDNA encoding VEGF were incorporated in microvascular stamps using a stereolithography apparatus (SLA).  The 
cells remained viable after encapsulation, as evidenced by the dark stain following treatment with an MTT reagent. 
  
104 
 
 
Figure 4.10  VEGF secretion from microvascular stamps.  NIH3T3 fibroblasts transfected with pDNA encoding 
VEGF were incorporated in microvascular stamps.  The amount of VEGF secreted from the microvascular stamps 
decreased over 7 days. Values and error bars represent the mean and standard deviation from four independent 
measurements. 
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Figure 4.11  Cell viability in microvascular stamps.  NIH3T3 fibroblasts transfected with pDNA encoding VEGF 
were incorporated in microvascular stamps.  The cell viability was measured on Days 1, 4, and 7, and the values 
were normalized to the cell viability measured 4 hours after encapsulation. Values and error bars represent the mean 
and standard deviation from four independent measurements. 
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Figure 4.12  Blood vessel formation from microvascular stamps.  (A)  Neovessels formed along microchannels 
in the microvascular stamp fabricated with cells that had been transfected with pDNA encoding VEGF.  (B) 
Microvascular stamp fabricated with cells that were not manipulated to secrete VEGF.  Images in A and B were 
further magnified in A1 and B1, respectively.  Scale bars represent 500 µm. 
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Figure 4.13  Inflammatory response from microvascular stamp with high cell density.  With an increased 
density of cells transfected with pDNA encoding VEGF (5 × 10
6
 cells/ml), microvascular stamps elicited a pro-
inflammatory response on the CAM, characterized by the formation of fibrous tissue on the surface of the vascular 
stamp.  Scale bar represents 500 µm. 
 
 
